Columns: General -- Sales -- Acquisition -- WAC
OSHPD ID | Manufacturer Name | Date Reported | Description | WAC at Acquisition | WAC Year Prior to Acquisition | WAC at Intro to Market | WAC Effective Date | WAC Increase Amount | WAC After Increase |
---|---|---|---|---|---|---|---|---|---|
Rx0000077 | AbbVie | 04/29/2024 | CREON 12000USP DELAYED-RELEASE 100CAP | 01/02/2024 | 19.78 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 12000USP DELAYED-RELEASE 250CAP | 01/02/2024 | 49.44 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 24000USP DELAYED-RELEASE 100CAP | 01/02/2024 | 39.20 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 24000USP DELAYED-RELEASE 250CAP | 01/02/2024 | 96.43 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 3000USP DELAYED-RELEASE 70CAP | 01/02/2024 | 5.85 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 36000USP DELAYED-RELEASE 100CAP | 01/02/2024 | 59.53 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 36000USP DELAYED-RELEASE 250CAP | 01/02/2024 | 148.80 | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 6000USP DELAYED-RELEASE 100CAP | 01/02/2024 | 9.89 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 140 mg Capsules, 120-count | 02/19/2024 | 726.10 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 140 mg Tablets, 28-count | 02/19/2024 | 508.27 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 280 mg Tablets, 28-count | 02/19/2024 | 508.27 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 420 mg Tablets, 28-count | 02/19/2024 | 508.27 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 70 mg Capsules, 28-count | 02/19/2024 | 508.27 | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA140 mg Capsules, 90-count | 02/19/2024 | 544.57 | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORIAHNN CAPSULES 300MG/1MG/0.5MG; 4x14 | 01/02/2024 | 54.95 | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORILISSA 150MG TABS, 4X7 PACK | 01/02/2024 | 54.95 | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORILISSA 200MG TABS, 4X14 PACK | 01/02/2024 | 54.95 | ||||
Rx0000077 | AbbVie | 04/29/2024 | RINVOQ 15MG 30 DAY BOTTLE | 01/02/2024 | 306.25 | ||||
Rx0000077 | AbbVie | 04/29/2024 | SKYRIZI INJ 150MG/ML SINGLE-DOSE PEN | 01/02/2024 | 1282.75 | ||||
Rx0000077 | AbbVie | 04/29/2024 | SKYRIZI INJ 150MG/ML SINGLE-DOSE PREFILLED SYRINGE | 01/02/2024 | 1282.75 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG BOTTLE 180 TABLETS | 01/02/2024 | 710.12 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG BOTTLE 180 TABLETS | 07/01/2024 | 229.01 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG BOTTLE, 120 TABLETS | 01/02/2024 | 473.41 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG BOTTLE, 120 TABLETS | 07/01/2024 | 152.67 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG UNIT DOSE, 1 TABLET | 01/02/2024 | 3.94 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG UNIT DOSE, 1 TABLET | 07/01/2024 | 1.27 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 10MG UNIT DOSE, 2 TABLETS | 01/02/2024 | 0.79 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 10MG UNIT DOSE, 2 TABLETS | 07/01/2024 | 0.25 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 10MG WALLET, 2 TABLETS X 7 | 01/02/2024 | 5.52 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 10MG WALLET, 2 TABLETS X 7 | 07/01/2024 | 1.78 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 50MG UNIT DOSE, 1 TABLET | 01/02/2024 | 1.97 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 50MG UNIT DOSE, 1 TABLET | 07/01/2024 | 0.64 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 50MG WALLET, 1 TABLET X 7 | 01/02/2024 | 13.81 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 50MG WALLET, 1 TABLET X 7 | 07/01/2024 | 4.45 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA START PACK, 4X7 DAY WALLET | 01/02/2024 | 102.18 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA START PACK, 4X7 DAY WALLET | 07/01/2024 | 32.95 | ||||
Rx0000021 | Acorda Therapeutics, Inc. | 04/05/2024 | Ampyra Oral Tablet Extended Release 12 Hour 10 MG Package Size 60 - 1 Bottle | 01/01/2024 | 386.99 | ||||
Rx0000021 | Acorda Therapeutics, Inc. | 04/05/2024 | Inbrija Inhalation Capsule 42 MG Package Size 60 - 1 Box | 01/01/2024 | 69.12 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | OPSUMIT® (macitentan)Strength:10 mg Package Size:15 Form:Tablet | 01/24/2024 | 277.83 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | OPSUMIT® (macitentan)Strength:10 mg Package Size:30 Form:Tablet | 01/24/2024 | 555.66 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1000 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1200 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1400 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1600 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1800mcg Package Size:1 Form:Vial | 01/24/2024 | 12.18 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200 mcg Package Size:140 Form:Tablet | 01/24/2024 | 1098.37 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200 mcg Package Size:60 Form:Tablet | 01/24/2024 | 470.73 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200+800 mcg Package Size:200 Form:Tablet | 01/24/2024 | 1098.36 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:400 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:600 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:800 mcg Package Size:60 Form:Tablet | 01/24/2024 | 732.06 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 100mg - 2 Capsules per blister pack - 30 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg - 3 Capsules per blister pack - 45 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg - 6 Capsules per blister pack - 90 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg-3 & 10mg-1 Capsules per blister pack - 45 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 1 Capsule per blister pack - 15 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 2 Capsules per blister pack - 30 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 4 Capsules per blister pack - 60 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-1 & 100mg - 1 Capsules per blister pack - 30 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-2 & 100mg - 2 Capsules per blister pack - 60 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-3 & 100mg - 1 Capsules per blister pack - 60 capsules per blister pack | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Sachet - 300mg - 15 Sachet | 04/09/2024 | 152.48 | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Sachet - 300mg - 30 Sachet | 04/09/2024 | 304.97 | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 1 BLISTER PACK in 1 CARTON > 10 TABLET, EQ 20MG BASE | 01/01/2024 | 196.00 | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 1 BLISTER PACK in 1 CARTON > 15 TABLET, EQ 20MG BASE | 01/01/2024 | 294.00 | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 2 BLISTER PACK in 1 CARTON / 15 TABLET, FILM COATED in 1 BLISTER PACK, EQ 20MG BASE | 01/01/2024 | 588.00 | ||||
Rx0000417 | Akebia Therapeutics, Inc. | 03/31/2024 | Auryxia (Ferric Citrate) 210 mg, 200 Tablets per Bottle | 02/01/2024 | 12.00 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Alcaine Ophthalmic Solution 0.5 % 15ml per package | 02/07/2024 | 2.45 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Flex cont | 02/07/2024 | 5.36 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Flex cont | 02/07/2024 | 5.36 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Glass Cont | 02/07/2024 | 5.63 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Glass Cont | 02/07/2024 | 5.63 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 0.5 % 15ml per package | 02/07/2024 | 5.36 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 1 % 5ml per package | 02/07/2024 | 3.43 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 15ml per package | 02/07/2024 | 6.86 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 2ml per package | 02/07/2024 | 2.50 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 5ml per package | 02/07/2024 | 4.13 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclomydril Ophthalmic Solution 0.2-1 % 5ml per package | 02/07/2024 | 3.51 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Isopto Atropine Ophthalmic Solution 1 % 5ml per package | 02/07/2024 | 3.26 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Miostat Intraocular Solution 0.01 % 12 vials per package | 02/07/2024 | 30.36 | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Mydriacyl Ophthalmic Solution 1 % 15ml per package | 02/07/2024 | 6.01 | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 10MG 28 COUNT | 04/01/2024 | 101.06 | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 10MG 60 COUNT | 04/01/2024 | 216.55 | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 25MG 28 COUNT | 04/01/2024 | 252.64 | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 25MG 60 COUNT | 04/01/2024 | 541.37 | ||||
Rx0000459 | AltaThera Pharmaceuticals LLC | 03/31/2024 | Sotalol hydrochloride - Injection: 10-mL vial containing sotalol hydrochloride 150 mg | 01/01/2024 | 297.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Alfuzosin HCl Tab ER 24HR 10 MG, 100 Each, Bottle | 04/01/2024 | 136.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Alitretinoin Gel 0.1%, 60 GM, Unit-of-Use, Tube | 04/01/2024 | 289.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 125 MCG (0.125 MG), 100 Each, Bottle | 04/01/2024 | 82.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 125 MCG (0.125 MG), 100 Each, Unit-Dose, Box | 04/01/2024 | 82.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 250 MCG (0.25 MG), 100 Each, Bottle | 04/01/2024 | 82.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 62.5 MCG (0.0625 MG), 100 Each, Bottle | 04/01/2024 | 82.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Donnatal Oral Elixir 16.2 MG/5ML 16.2-0.1037-0.0194-0.0065 MG/5ML, 480 ML, Bottle | 04/01/2024 | 102.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Donnatal Oral Elixir 16.2 MG/5ML PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 120 ML, Bottle | 04/01/2024 | 24.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 120 ML, Bottle | 04/01/2024 | 24.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 480 ML, Bottle | 04/01/2024 | 102.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Tab 16.2-0.1037-0.0194-0.0065 MG, 100 Each, Bottle | 04/01/2024 | 67.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 10 MG (Base Eq), 12 Each, Unit-Dose, Box | 04/01/2024 | 25.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 15 MG (Base Eq), 12 Each, Unit-Dose, Box | 04/01/2024 | 33.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 30 MG (Base Eq), 12 Each, Unit-Dose, Box | 04/01/2024 | 42.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Tranylcypromine Sulfate Tab 10 MG, 100 Each, Bottle | 04/01/2024 | 88.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Triamterene Cap 100 MG, 100 Each, Bottle | 04/01/2024 | 131.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Triamterene Cap 50 MG, 100 Each, Bottle | 04/01/2024 | 131.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Zonisamide Cap 100 MG, 100 Each, Bottle | 04/01/2024 | 108.00 | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Zonisamide Cap 25 MG, 100 Each, Bottle | 04/01/2024 | 83.00 | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | DOXYCYCLINE TABLET 100MG 30UD | 01/05/2024 | 6.00 | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | MESALAMINE DR CAP 400MG 20UD | 03/22/2024 | 36.80 | ||||
Rx0000231 | American Health Packaging | 06/17/2024 | METHYLPHENIDATE HCL TABLET CII 5MG 30UD | 05/28/2024 | 6.60 | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | RIFAMPIN CAPS 150MG 30UD | 01/05/2024 | 47.78 | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | RIFAMPIN CAPSULE 300MG 100UD | 01/05/2024 | 77.00 | ||||
Rx0000128 | American Regent | 04/18/2024 | ACETYLCYSTEINE SOLUTION 10%, 4ML, PKG OF 25 | 02/01/2024 | 11.75 | ||||
Rx0000128 | American Regent | 10/15/2024 | ACETYLCYSTEINE SOLUTION 10%, 4ML, PKG OF 25 | 08/01/2024 | 11.75 | ||||
Rx0000128 | American Regent | 04/02/2024 | Caffeine & Sodium Benzoate, 250mg/ml 2mL SDV, 10pk | 02/01/2024 | 21.40 | ||||
Rx0000128 | American Regent | 10/15/2024 | Caffeine & Sodium Benzoate, 250mg/ml 2mL SDV, 10pk | 08/01/2024 | 23.00 | ||||
Rx0000128 | American Regent | 10/15/2024 | Drug Product Description HYDROXYZINE HCL, 50MG/ML, 1ML SDV, PKG. OF 25 | 08/01/2024 | 33.25 | ||||
Rx0000128 | American Regent | 04/18/2024 | HYDROXYZINE HCL, 25MG/ML, 1ML SDV, PKG. OF 25 | 02/01/2024 | 32.00 | ||||
Rx0000128 | American Regent | 10/15/2024 | HYDROXYZINE HCL, 25MG/ML, 1ML SDV, PKG. OF 25 | 08/01/2024 | 30.25 | ||||
Rx0000128 | American Regent | 04/18/2024 | HYDROXYZINE HCL, 50MG/ML, 1ML SDV, PKG. OF 25 | 02/01/2024 | 35.25 | ||||
Rx0000128 | American Regent | 10/15/2024 | Injectafer Intravenous Solution 750 MG/15ML | 07/01/2024 | 41.64 | ||||
Rx0000128 | American Regent | 10/15/2024 | MULTRYS (TRACE ELEMENTS INJECTION 4, USP, PKG. OF 25 | 08/01/2024 | 25.75 | ||||
Rx0000128 | American Regent | 10/15/2024 | Tralement (TRACE ELEMENTS INJECTION 4, USP, PKG. OF 25 | 08/01/2024 | 27.75 | ||||
Rx0000069 | Amgen | 04/30/2024 | Aimovig, 140 mg/mL single-dose prefilled SureClick autoinjector | 01/05/2024 | 14.76 | ||||
Rx0000069 | Amgen | 04/30/2024 | Aimovig, 70 mg/mL single-dose prefilled SureClick autoinjector | 01/05/2024 | 14.76 | ||||
Rx0000069 | Amgen | 04/30/2024 | Blincyto, 35 mcg lyophilized vial, 1 pk | 01/05/2024 | 245.01 | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 5mg oral solution AMP, 28 pk | 01/05/2024 | 13.25 | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 5mg tablet, 60 pk | 01/05/2024 | 28.39 | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 7.5mg tablet, 60 pk | 01/05/2024 | 28.39 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 1 pack | 01/05/2024 | 88.12 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 1 pack | 08/23/2024 | 55.52 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 4 pack | 01/05/2024 | 352.47 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 4 pack | 08/23/2024 | 222.09 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 1 pack | 01/05/2024 | 88.12 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 1 pack | 08/23/2024 | 55.52 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 4 pack | 01/05/2024 | 352.47 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 4 pack | 08/23/2024 | 222.09 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg (1 mL), Vial (EA), 4 pack | 01/05/2024 | 176.23 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg (1mL), Vial (EA), 1 pack | 01/05/2024 | 44.06 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 1 pack | 01/05/2024 | 44.06 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 1 pack | 08/23/2024 | 27.76 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 4 pack | 01/05/2024 | 176.23 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 4 pack | 08/23/2024 | 111.05 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 1 pack | 01/05/2024 | 44.06 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 1 pack | 08/23/2024 | 27.76 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 4 pack | 01/05/2024 | 176.23 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 4 pack | 08/23/2024 | 111.05 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 50mg/mL, Syringe (ML), 1 pack | 01/05/2024 | 88.12 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 50mg/mL, Syringe (ML), 1 pack | 08/23/2024 | 55.52 | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 50mg/mL, Syringe (ML), 4 pack | 01/05/2024 | 352.47 | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 50mg/mL, Syringe (ML), 4 pack | 08/23/2024 | 222.09 | ||||
Rx0000069 | Amgen | 04/30/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 1 pk | 01/05/2024 | 57.96 | ||||
Rx0000069 | Amgen | 07/25/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 1 pk | 06/27/2024 | 34.69 | ||||
Rx0000069 | Amgen | 04/30/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 2 pk | 01/05/2024 | 115.92 | ||||
Rx0000069 | Amgen | 07/25/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 2 pk | 06/27/2024 | 69.38 | ||||
Rx0000069 | Amgen | 04/30/2024 | Imlygic, 106 (1 million) PFU/mL (1.0 mL) single-use vial | 01/05/2024 | 3.17 | ||||
Rx0000069 | Amgen | 04/30/2024 | Imlygic, 108 (100 million) PFU/mL (1.0 mL) single-use vial | 01/05/2024 | 316.82 | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 10 mg (2mg/mL) lyophilized vial, 1 pk | 01/05/2024 | 24.83 | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 10 mg (2mg/mL) lyophilized vial, 1 pk | 06/27/2024 | 24.50 | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 30 mg (2mg/mL) lyophilized vial, 1 pk | 01/05/2024 | 74.48 | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 30 mg (2mg/mL) lyophilized vial, 1 pk | 06/27/2024 | 73.51 | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 60 mg lyophilized vial, 1 pk | 01/05/2024 | 148.96 | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 60 mg lyophilized vial, 1 pk | 06/27/2024 | 147.02 | ||||
Rx0000069 | Amgen | 04/30/2024 | Lumakras, 120mg Tablet, 240 pack | 01/05/2024 | 1005.53 | ||||
Rx0000069 | Amgen | 04/30/2024 | Lumakras, 320mg Tablet, 90 pack | 01/05/2024 | 1005.53 | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 125 mcg, 0.25mL (500 mcg/mL) single-use vial | 01/05/2024 | 59.62 | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 125 mcg, 0.25mL (500 mcg/mL) single-use vial | 06/27/2024 | 58.85 | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 250 mcg, 0.5mL (500 mcg/mL) single-use vial | 01/05/2024 | 119.25 | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 250 mcg, 0.5mL (500 mcg/mL) single-use vial | 06/27/2024 | 117.70 | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 500 mcg, 1.0mL (500 mcg/mL) single-use vial | 01/05/2024 | 238.50 | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 500 mcg, 1.0mL (500 mcg/mL) single-use vial | 06/27/2024 | 235.40 | ||||
Rx0000069 | Amgen | 04/30/2024 | Otezla, 10mg (4)-20mg (4)-30g (47), Tablet Dose Pack, 55 pack | 3398.00 | 3283.09 | 3591.69 | 01/05/2024 | 230.02 | |
Rx0000069 | Amgen | 07/25/2024 | Otezla, 10mg (4)-20mg (4)-30g (47), Tablet Dose Pack, 55 pack | 3398.00 | 3283.09 | 3591.69 | 06/27/2024 | 144.92 | |
Rx0000069 | Amgen | 04/30/2024 | Otezla, 30mg, Tablet, 60 pack | 3398.00 | 3283.09 | 3591.69 | 01/05/2024 | 230.02 | |
Rx0000069 | Amgen | 07/25/2024 | Otezla, 30mg, Tablet, 60 pack | 3398.00 | 3283.09 | 3591.69 | 06/27/2024 | 144.92 | |
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 10 mg/2 mL single-dose vial, 1 pack | 01/05/2024 | 18.72 | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 10 mg/2 mL single-dose vial, 10 pack | 01/05/2024 | 187.26 | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 2.5 mg/0.5 mL single-dose vial, 1 pack | 01/05/2024 | 4.68 | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 2.5 mg/0.5 mL single-dose vial, 10 pack | 01/05/2024 | 46.81 | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 5 mg/1 mL single-dose vial, 1 pack | 01/05/2024 | 9.36 | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 5 mg/1 mL single-dose vial, 10 pack | 01/05/2024 | 93.63 | ||||
Rx0000069 | Amgen | 04/30/2024 | Prolia, 60 mg, 1.0mL (60 mg/mL) prefilled syringe | 01/05/2024 | 112.09 | ||||
Rx0000069 | Amgen | 07/25/2024 | Prolia, 60 mg, 1.0mL (60 mg/mL) prefilled syringe | 06/27/2024 | 49.49 | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 140 mg, 1.0 mL (140 mg/mL) autoinjector, 2 pack | 01/05/2024 | 11.01 | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 140 mg, 1.0 mL (140 mg/mL) prefilled syringe | 01/05/2024 | 5.50 | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 420 mg, 3.5 mL (120 mg/mL) Pushtronex system | 01/05/2024 | 11.93 | ||||
Rx0000069 | Amgen | 04/30/2024 | Vectibix, 100 mg, 5 mL (20 mg/mL) single-use vial | 01/05/2024 | 78.47 | ||||
Rx0000069 | Amgen | 07/25/2024 | Vectibix, 100 mg, 5 mL (20 mg/mL) single-use vial | 06/27/2024 | 77.45 | ||||
Rx0000069 | Amgen | 04/30/2024 | Vectibix, 400 mg, 20 mL (20 mg/mL) single-use vial | 01/05/2024 | 313.89 | ||||
Rx0000069 | Amgen | 07/25/2024 | Vectibix, 400 mg, 20 mL (20 mg/mL) single-use vial | 06/27/2024 | 309.81 | ||||
Rx0000069 | Amgen | 04/30/2024 | Xgeva, 120 mg /1.7 mL (70 mg/mL) single-use vial | 01/05/2024 | 206.19 | ||||
Rx0000069 | Amgen | 07/25/2024 | Xgeva, 120 mg /1.7 mL (70 mg/mL) single-use vial | 06/27/2024 | 91.04 | ||||
Rx0000122 | Amneal Pharmaceuticals | 07/02/2024 | Budesonide Inhalation Suspension 0.25 MG/2ML 30 ampules | 08/19/2024 | 175.93 | ||||
Rx0000122 | Amneal Pharmaceuticals | 07/02/2024 | Budesonide Inhalation Suspension 0.5 MG/2ML 30 ampules | 08/19/2024 | 240.89 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | BiDil 20mg/37.5mg 90 (Isosorbide Dinitrate/Hydralazine HCl Tablets) | 01/01/2024 | 21.29 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBI 40mg (azilsartan medoxomil) 30 tablets | 01/01/2024 | 21.59 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBI 80mg (azilsartan medoxomil) 30 tablets | 01/01/2024 | 23.47 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBYCLOR 40mg/12.5mg (azilsartan medoxomil / chlorthalidone) 30 tablets | 01/01/2024 | 22.15 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBYCLOR 40mg/25mg (azilsartan medoxomil / chlorthalidone) 30 tablets | 01/01/2024 | 22.15 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Gliadel 7.7mg 8 Implant Wafers | 01/01/2024 | 3519.73 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | HORIZANT 300MG (gabapentin enacarbil) 30 extended-release tablets | 01/01/2024 | 46.84 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | HORIZANT 600MG (gabapentin enacarbil) 30 extended-release tablets | 01/01/2024 | 46.84 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 30mg/5mL prefilled oral syringe 12x5 ml | 01/01/2024 | 48.56 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 60mg/10ml Oral Solution 237ml 8oz | 01/01/2024 | 188.99 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 60mg/10mL prefilled oral syringe 12x10ml | 01/01/2024 | 97.11 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | SOTYLIZE 5mg/ml (sotalol hydrochloride) oral solution 250 ml | 01/01/2024 | 49.00 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | SOTYLIZE 5mg/ml (sotalol hydrochloride) oral solution 480ml | 01/01/2024 | 94.08 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 10mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 15mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 2.5mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 20mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 30mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 5mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 7.5mg, 30 (Dextroamphetamine Sulfate Tablets) | 06/01/2024 | 60.65 | ||||
Rx0000359 | Ardelyx, Inc. | 04/23/2024 | Ibsrela Oral Tablet 50 MG, 60 Each, Unit-of-Use, Bottle | 01/01/2024 | 85.00 | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Cresemba, 186 mg / 14 capsules per blister pack | 01/18/2024 | 74.92 | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Cresemba, 372 mg / 1 vial | 01/18/2024 | 18.23 | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 40 mg / 120 capsules per bottle | 01/18/2024 | 682.50 | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 40 mg / 120 tablets per bottle | 01/18/2024 | 682.50 | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 80 mg / 60 tablets per bottle | 01/18/2024 | 682.50 | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 120ct TABLET 100MG | 06/01/2024 | 490.91 | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 120ct TABLET 150MG | 06/01/2024 | 490.91 | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 60ct TABLET 100MG | 06/01/2024 | 245.45 | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 60ct TABLET 150MG | 06/01/2024 | 245.45 | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 04/24/2024 | Fotivda Oral Capsule 0.89 MG, 21 Each, Bottle | 01/22/2024 | 1400.00 | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 10/25/2024 | Fotivda Oral Capsule 0.89 MG, 21 Each, Bottle | 07/22/2024 | 882.00 | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 04/24/2024 | Fotivda Oral Capsule 1.34 MG, 21 Each, Bottle | 01/22/2024 | 1400.00 | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 10/25/2024 | Fotivda Oral Capsule 1.34 MG, 21 Each, Bottle | 07/22/2024 | 882.00 | ||||
Rx0000277 | Avion Pharmaceuticals, LLC | 04/23/2024 | Balcoltra Oral Tablet 0.1 - 20 mg/mcg pkg, size 1 - Insert | 01/01/2024 | 8.01 | ||||
Rx0000277 | Avion Pharmaceuticals, LLC | 04/23/2024 | Balcoltra Oral Tablet 0.1 - 20 mg/mcg pkg, size 3 | 01/01/2024 | 24.03 | ||||
Rx0000108 | AvKare | 07/31/2024 | Ergocalciferol (vitamin D2) Capsule 1,250 mcg 100ct | 04/12/2024 | 112.96 | ||||
Rx0000108 | AvKare | 07/31/2024 | Letrozole Tablet 2.5mg 90ct | 06/22/2024 | 190.59 | ||||
Rx0000108 | AvKare | 07/31/2024 | losartan potassium/hydrochlorothiazide tablet 100 mg-12.5 mg 90ct | 04/15/2024 | 297.02 | ||||
Rx0000108 | AvKare | 07/31/2024 | losartan potassium/hydrochlorothiazide tablet 100 mg-25 mg 90ct | 04/15/2024 | 297.31 | ||||
Rx0000108 | AvKare | 07/31/2024 | Losartan potassium/hydrochlorothiazide tablet 50 mg-12.5 mg 90ct | 04/15/2024 | 227.13 | ||||
Rx0000108 | AvKare | 07/31/2024 | Progesterone Capsule 100mg 100ct | 05/15/2024 | 583.98 | ||||
Rx0000108 | AvKare | 07/31/2024 | Progesterone Capsule 200mg 100ct | 05/15/2024 | 970.83 | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 400 mg-80 mg 100ct | 04/15/2024 | 116.97 | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 400 mg-80 mg 500ct | 04/15/2024 | 299.00 | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 800 mg-160 mg 100ct | 04/15/2024 | 144.36 | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 800 mg-160 mg 500ct | 04/15/2024 | 299.00 | ||||
Rx0000108 | AvKare | 04/29/2024 | URSODIOL 500MG TABLET 100ct | 02/29/2024 | 216.63 | ||||
Rx0000429 | Axsome Therapeutics, Inc. | 04/29/2024 | Sunosi Tablets 150mg 30 | 755.00 | 699.60 | 660.00 | 01/01/2024 | 49.38 | |
Rx0000429 | Axsome Therapeutics, Inc. | 04/29/2024 | Sunosi Tablets 75mg 30 | 755.00 | 699.60 | 660.00 | 01/01/2024 | 49.38 | |
Rx0000430 | Azurity Pharmaceuticals | 04/17/2024 | QBRELIS® (lisinopril) Oral Solution, 1 mg / mL, 150 mL | 01/01/2024 | 33.61 | ||||
Rx0000430 | Azurity Pharmaceuticals | 03/31/2024 | Xatmep 2.5/ml (methotrexate) Oral Solution 120ml | 01/01/2024 | 208.35 | ||||
Rx0000430 | Azurity Pharmaceuticals | 03/31/2024 | Xatmep 2.5mg/ml (methotrexate) Oral Solution 60ml | 01/01/2024 | 109.45 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ALREX® (loteprednol etabonate ophthalmic suspension 0.2%), 10mL | 01/01/2024 | 33.85 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ALREX® (loteprednol etabonate ophthalmic suspension 0.2%), 5mL | 01/01/2024 | 16.93 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BEPREVE Ophthalmic Solution USP, 1.5%, 10mL | 01/01/2024 | 31.15 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BEPREVE Ophthalmic Solution USP, 1.5%, 5mL | 01/01/2024 | 16.29 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BESIVANCE® (besifloxacin ophthalmic suspension 0.6%), 5mL | 01/01/2024 | 12.83 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic Gel 0.5%), 5g | 01/01/2024 | 14.45 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic Ointment 0.5%), 3.5g | 01/01/2024 | 20.33 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 10mL | 01/01/2024 | 36.01 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 15mL | 01/01/2024 | 53.54 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 5mL | 01/01/2024 | 18.00 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38%, 5g | 01/01/2024 | 14.45 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | MIOCHOL®-E (acetylcholine chloride intraocular solution), 20mg/2 mL, Vial | 01/01/2024 | 7.28 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | PROLENSA (bromfenac ophthalmic solution) 0.07% 3mL | 01/01/2024 | 20.20 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | TIMOPTIC® in OCUDOSE® (TIMOLOL MALEATE OPHTHALMIC SOLUTION - New NDC), 0.50%, 0.3mL, 60ct | 01/01/2024 | 36.13 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | TIMOPTIC® in OCUDOSE® (TIMOLOL MALEATE OPHTHALMIC SOLUTION) 0.25%, 0.3mL, 60ct | 01/01/2024 | 31.68 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | VYZULTA (latanoprostene bunod ophthalmic solution) 0.024%, 2.5mL | 01/01/2024 | 14.45 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | VYZULTA (latanoprostene bunod ophthalmic solution) 0.024%, 5mL | 01/01/2024 | 28.90 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | XIIDRA® (lifitegrast ophthalmic solution) 5%, 60ct | 684.45 | 633.75 | 426.73 | 01/01/2024 | 17.11 | |
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZIRGAN (Ganciclovir Ophthalmic Gel 0.15%), 5mL | 01/01/2024 | 26.61 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic Suspension), 10mL | 01/01/2024 | 37.48 | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic Suspension), 5mL | 01/01/2024 | 18.74 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 174mg 30ct | 01/01/2024 | 182.22 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 348mg 30ct | 01/01/2024 | 240.21 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 522mg 30ct | 01/01/2024 | 546.66 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ARAZLO (tazarotene) Lotion, 0.045%, 45g | 01/01/2024 | 15.59 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 1mg 1,000s | 01/01/2024 | 1347.40 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets .5mg 100s | 01/01/2024 | 102.99 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 1mg 100s | 01/01/2024 | 137.58 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 2mg 100s | 01/01/2024 | 219.25 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | BRYHALI (halobetasol propionate) Lotion 0.01%, 100g | 01/01/2024 | 15.58 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | BRYHALI (halobetasol propionate) Lotion 0.01%, 60g | 01/01/2024 | 9.35 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | DEMSER® (metyrosine), 250mg Capsules, 100ct | 01/01/2024 | 631.91 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | Duobrii (halobetasol propionate and tazarotene) Lotion 0.01%/0.045%, 1 | 01/01/2024 | 30.26 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | JUBLIA® (efinaconazole) Topical Solution 10%, 4mL | 01/01/2024 | 14.91 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | JUBLIA® (efinaconazole) Topical Solution 10%, 8mL | 01/01/2024 | 29.83 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON 60mg /SYRUP (pyridostigmine bromide) 473mL 1 Bottle | 01/01/2024 | 40.04 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON 60mg TABLETS 100s (pyridostigmine bromide) | 01/01/2024 | 49.29 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON TIMESPAN 180mg TABLETS (pyridostigmine bromide) 30 CT | 01/01/2024 | 28.05 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MYSOLINE 250 mg TABLETS, 100s (primidone) | 01/01/2024 | 165.22 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MYSOLINE 50 mg TABLETS, 100s (primidone) | 01/01/2024 | 48.01 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | SILIQ (brodalumab) Injection 210mg/1.5mL (1 box of 2 syringes) | 01/01/2024 | 470.23 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 2.5mg Tablets, 90s | 01/01/2024 | 41.63 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 1,000s | 01/01/2024 | 589.99 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 30s | 01/01/2024 | 17.70 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 90s | 01/01/2024 | 53.11 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 2.5mg Tablets, 30s | 01/01/2024 | 13.88 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 1,000s | 01/01/2024 | 839.49 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 30s | 01/01/2024 | 25.19 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 90s | 01/01/2024 | 75.55 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 5mg Tablets, 30s | 01/01/2024 | 16.09 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 5mg Tablets, 90s | 01/01/2024 | 48.27 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 150mg Tablets, 30ct | 01/01/2024 | 179.91 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 150mg Tablets, 90ct | 01/01/2024 | 539.76 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 300mg Tablets, 30ct | 01/01/2024 | 237.49 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ZELAPAR (selegiline HCI) 1.25mg Orally Disintegrating Tablets, 60ct | 01/01/2024 | 236.15 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.45% SODIUM CHL INJ,1000ML, 14 USPVIAFLEX PLASTIC CONTAINER | 07/01/2024 | 7.23 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ USP 50 ML, 96 MINI-BAG TM VIAFLEX CONT. | 07/01/2024 | 0.20 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ USP, 100ML, 80 MINI-BAG PLUS CONT | 07/01/2024 | 69.56 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ. USP 100 ML, 96 MINI-BAG TM VIAFLEX CONT | 07/01/2024 | 21.71 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL 100ML, 96 MINI-BAG VIAFLEX CONT | 07/01/2024 | 20.35 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL IRRIG, USP, 3000ML ARTHROMATIC, 4 Plastic Cont. | 07/01/2024 | 9.68 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL IRRIG, USP, 3000ML ARTHROMATIC, 4 Plastic Cont. | 07/01/2024 | 9.68 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD.CHL.IRRIG. USP 3000ML, 4 UROMATIC CONTAINER | 07/01/2024 | 9.78 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD.CHL.IRRIG. USP 3000ML, 4 UROMATIC CONTAINER | 07/01/2024 | 9.78 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 10% DEXTROSE INJECTION USP 250ML MIGRATED, 36 Flex Cont. | 07/01/2024 | 29.81 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 20 MEQ POT CHL IN .9% SOD CHLINJ,USP 1000ML, 14 Flex Cont. | 07/01/2024 | 12.29 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 20MEQ POT CHL IN 5% DEX&0.9%SOD CHL INJ, USP 1000ML, 14 Flex Cont. | 07/01/2024 | 12.29 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX AND 0.45% SOD CHL INJ,USP 1000ML, 14 Flex Cont. | 07/01/2024 | 11.35 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX AND 0.9% SOD CHL ING,USP 1000ML, 14 Flex Cont. | 07/01/2024 | 10.79 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX INJ, USP, 100 ML , 80 MINI-BAG PLUS CONTAINER | 07/01/2024 | 69.56 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX INJ, USP, 50ML, 80 MINI-BAG PLUS CONTAINER | 07/01/2024 | 69.56 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | DEXTROSE 5% INJECTION USP 1000ML MIGRATED, 14 flex cont. | 07/01/2024 | 6.40 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | DEXTROSE 5% INJECTION USP 250ML MIGRATED, 36 Flex Cont. | 07/01/2024 | 12.81 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | LACTATED RINGERS & 5% DEXTROSEINJ, USP 1000ML, 14 Flex Cont. | 07/01/2024 | 6.89 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | LACTATED RINGERS IRRIG, 3000 ML ARTHROMATIC, 4 Plastic Cont. | 07/01/2024 | 6.13 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | NACL 0.9% INJ USP 50ML, 96 MINI-BAG TM VIAFLEX MIGRATED | 07/01/2024 | 20.91 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | PLASMA-LYTE A INJECTION PH 7.4MULTIPLE 1000ML 14 Flex Cont. | 07/01/2024 | 31.11 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP 100ML, 96 MINI- BAG TM VIAFLEX MIGRATED | 07/01/2024 | 20.91 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP 50ML, 80 MINI-BAG PLUS CONT MIGRATED | 07/01/2024 | 69.56 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP250ML, 36 VIAFLEXPLASTIC MIGRATED | 07/01/2024 | 12.74 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | STERILE WATER FOR INJ.USP 1000ML, 14 Flex Cont | 07/01/2024 | 11.15 | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | STERILE WATER FOR INJ.USP 1000ML, 14 Flex Cont | 07/01/2024 | 11.15 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 0.5 MG TABLET 9 count | 01/01/2024 | 78.30 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 0.5 MG TABLET 90 count | 01/01/2024 | 783.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1 MG TABLET 9 count | 01/01/2024 | 78.30 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1 MG TABLET 90 count | 01/01/2024 | 783.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1.5 MG TABLET 9 count | 01/01/2024 | 78.30 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1.5 MG TABLET 90 count | 01/01/2024 | 783.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2 MG TABLET 9 count | 01/01/2024 | 78.30 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2 MG TABLET 90 count | 01/01/2024 | 783.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2.5 MG TABLET 9 count | 01/01/2024 | 78.30 | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2.5 MG TABLET 90 count | 01/01/2024 | 783.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | BETASERON-01 | 01/01/2024 | 39.43 | ||||
Rx0000024 | Bayer | 03/31/2024 | BETASERON-35 | 01/01/2024 | 552.02 | ||||
Rx0000024 | Bayer | 03/31/2024 | Nexavar 200mg 120 Tablets | 01/01/2024 | 1443.60 | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 21 count bottle | 01/01/2024 | 324.45 | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 28 count bottle | 01/01/2024 | 432.60 | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 3x28 count bottle | 01/01/2024 | 1297.80 | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 4x21 count bottle | 01/01/2024 | 1297.80 | ||||
Rx0000024 | Bayer | 03/31/2024 | VITRAKVI 100MG CAPS BT 1x60 | 01/01/2024 | 1856.40 | ||||
Rx0000024 | Bayer | 03/31/2024 | Vitrakvi 20 mg/mL oral solution | 01/01/2024 | 825.00 | ||||
Rx0000024 | Bayer | 03/31/2024 | VITRAKVI 25MG CAPS BT 1x60 | 01/01/2024 | 618.60 | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 250mg Capsule 60ct | 01/17/2024 | 89.35 | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 250mg Capsule 60ct | 07/22/2024 | 93.82 | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 250mg Packet 60ct | 01/17/2024 | 89.35 | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 250mg Packet 60ct | 07/22/2024 | 93.82 | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 500mg Capsule 60ct | 01/17/2024 | 178.70 | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 500mg Capsule 60ct | 07/22/2024 | 187.63 | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 500mg Packet 60ct | 01/17/2024 | 178.70 | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 500mg Packet 60ct | 07/22/2024 | 187.63 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | BRINEURA 150 mg/5 mL INJ, Kit (Two 5 mL vials (30mg/ml) (IEV)-one 5ml vial) | 04/01/2024 | 1279.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | NAGLAZYME 1MG/ML INJ, (5 mL vial) | 04/01/2024 | 46.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 10MG/0.5ML INJ,SYR,0.5MLsingle-dose prefilled syringe | 04/01/2024 | 15.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 2.5MG/0.5ML INJ,SYR,0.5ML single-dose prefilled syringe | 04/01/2024 | 15.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 20MG/ML INJ,SYR,1ML single-dose prefilled syringe | 04/01/2024 | 15.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 20MG/ML INJ,SYR,1ML Ten 1 mL single- dose prefilled syringes | 04/01/2024 | 150.00 | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | VIMIZIM 1MG/ML INJ,SOLN,5ML vial | 04/01/2024 | 27.00 | ||||
Rx0000038 | Boehringer Ingelheim | 04/26/2024 | OFEV 100MG CAPSULE 60 | 01/01/2024 | 499.87 | ||||
Rx0000038 | Boehringer Ingelheim | 04/26/2024 | OFEV 150MG CAPSULE 60 | 01/01/2024 | 499.87 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 250 mL infusion bag and metal cassette | 419500.00 | 419500.00 | 419500.00 | 01/01/2024 | 41152.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 50 mL infusion bag and metal cassette | 419500.00 | 419500.00 | 419500.00 | 01/01/2024 | 41152.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 500 mL infusion bag and metal cassette | 419500.00 | 419500.00 | 419500.00 | 01/01/2024 | 41152.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | BREYANZI® Carton up to 4 vials of cryopreserved CAR-positive T cells | 410310.00 | 410310.00 | 410310.00 | 01/01/2024 | 40250.43 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 2.5 mg tablet 60 count bottle | 01/01/2024 | 33.64 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 2.5 mg tablet pack of 100 | 01/01/2024 | 56.08 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet 60 count bottle | 01/01/2024 | 33.64 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet 74 count bottle | 01/01/2024 | 41.50 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet pack of 100 | 01/01/2024 | 56.08 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet pack of 74 | 01/01/2024 | 41.50 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | IDHIFA® 100mg, 30 Tablets/Bottle | 25742.52 | 24872.00 | 24872.00 | 01/01/2024 | 1924.22 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | IDHIFA® 50mg, 30 Tablets/Bottle | 25742.52 | 24872.00 | 24872.00 | 01/01/2024 | 1924.22 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | INREBIC® 100mg, 120 Capsules/Bottle | 21000.00 | 21000.00 | 21000.00 | 01/01/2024 | 1494.97 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ONUREG® 200 mg tablet pack of 7 | 10579.06 | 10579.06 | 10579.06 | 01/01/2024 | 720.68 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ONUREG® 300 mg tablet pack of 7 | 10579.06 | 10579.06 | 10579.06 | 01/01/2024 | 720.68 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 125 mg Solution, 1ml Single Dose Prefilled Auto-injector, pack of 4 Auto-Injectors | 01/01/2024 | 322.37 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 125 mg Solution, 1ml Single Dose Prefilled Syringe, pack of 4 Syringes | 01/01/2024 | 322.37 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 250 mg lyophilized powder | 01/01/2024 | 48.30 | ||||
Rx0000078 | Bristol Myers Squibb | 10/15/2024 | ORENCIA® 250 mg lyophilized powder | 07/01/2024 | 34.28 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 50 mg/0.4ml Solution, 0.4ml Single Dose Prefilled Syringe, pack of 4 Syringes | 01/01/2024 | 322.37 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 87.5 mg/0.7ml Solution, 0.7ml Single Dose Prefilled Syringe, pack of 4 Syringes | 01/01/2024 | 322.37 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 1 mg capsule pack of 100 | 81936.32 | 79165.53 | 49740.00 | 01/01/2024 | 6182.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 1 mg capsule pack of 21 | 17206.63 | 16624.76 | 10445.40 | 01/01/2024 | 1298.42 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 2 mg capsule pack of 100 | 81936.32 | 79165.53 | 49740.00 | 01/01/2024 | 6182.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 2 mg capsule pack of 21 | 17206.63 | 16624.76 | 10445.40 | 01/01/2024 | 1298.42 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 3 mg capsule pack of 100 | 81936.32 | 79165.53 | 49740.00 | 01/01/2024 | 6182.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 3 mg capsule pack of 21 | 17206.63 | 16624.76 | 10445.40 | 01/01/2024 | 1298.42 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 4 mg capsule pack of 100 | 81936.32 | 79165.53 | 49740.00 | 01/01/2024 | 6182.95 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 4 mg capsule pack of 21 | 17206.63 | 16624.76 | 10445.40 | 01/01/2024 | 1298.42 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 100 mg tablet, bottle of 30 | 01/01/2024 | 1032.81 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 140 mg tablet, bottle of 30 | 01/01/2024 | 1032.81 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 20 mg tablet, bottle of 60 | 01/01/2024 | 573.04 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 50 mg tablet, bottle of 60 | 01/01/2024 | 1146.08 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 70 mg tablet, bottle of 60 | 01/01/2024 | 1146.08 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 80 mg tablet, bottle of 30 | 01/01/2024 | 1032.81 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.23, 0.46MG TITR STR PCK 7CT US (Wallet) | 1649.32 | 1649.32 | 1649.32 | 01/01/2024 | 117.41 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.23,0.46,0.92MG 28CT KIT US | 7636.64 | 7636.64 | 7636.64 | 01/01/2024 | 469.65 | |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.92MG CAP 30CT BTL US | 7068.49 | 7068.49 | 7068.49 | 01/01/2024 | 503.20 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Firdapse 10mg Tablet 240/Bottle | 01/01/2024 | 3149.88 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Firdapse Blister shelf pack of 120 - 10mg tablets | 01/01/2024 | 1574.94 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 0.05MG/ML Oral Suspension | 1495.00 | 1431.00 | 957.10 | 01/22/2024 | 90.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 0.05MG/ML Oral Suspension 340 | 01/22/2024 | 90.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 10mg Tablet | 1186.00 | 1108.00 | 568.80 | 01/22/2024 | 69.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 10mg Tablet 30 | 01/22/2024 | 69.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 12mg Tablet | 1186.00 | 1108.00 | 568.80 | 01/22/2024 | 69.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 12mg Tablet 30 | 01/22/2024 | 69.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 2mg Tablet | 586.00 | 561.00 | 284.40 | 01/22/2024 | 35.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 2mg Tablet 30 | 01/22/2024 | 35.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 4mg Tablet | 1186.00 | 1108.00 | 568.80 | 01/22/2024 | 69.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 4mg Tablet 30 | 01/22/2024 | 69.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 6mg Tablet | 1186.00 | 1108.00 | 568.80 | 01/22/2024 | 69.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 6mg Tablet 30 | 01/22/2024 | 69.00 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 8mg Tablet | 1186.00 | 1108.00 | 568.80 | 01/22/2024 | 69.00 | |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 8mg Tablet 30 | 01/22/2024 | 69.00 | ||||
Rx0000139 | Chiesi USA | 04/11/2024 | Cleviprex injectable emulsion 25mg/50mL 10 vials in 1 box - Emulsion | 663.52 | 900.00 | 850.00 | 01/01/2024 | 24.92 | |
Rx0000139 | Chiesi USA | 04/11/2024 | Cleviprex injectable emulsion 50mg/100mL 10 vials in 1 box - Emulsion | 1327.04 | 1800.00 | 1700.00 | 01/01/2024 | 49.84 | |
Rx0000139 | Chiesi USA | 04/09/2024 | Curosurf® 1.5ml 80mg/mL 1 1.5mL vial - Suspension | 01/01/2024 | 26.67 | ||||
Rx0000139 | Chiesi USA | 04/09/2024 | Curosurf® 3.0ml 80mg/mL 1 3.0mL vial - Suspension | 01/01/2024 | 52.59 | ||||
Rx0000139 | Chiesi USA | 04/08/2024 | Ferriprox ORAL SOLUTION 100mg/1mL 1 bottle of 500 mL - Solution | 6363.07 | 5843.04 | 4533.00 | 01/04/2024 | 572.89 | |
Rx0000139 | Chiesi USA | 04/08/2024 | Ferriprox TD 1000mg FILM COATED TABLETS 1000mg 1 carton of 5 blister packs - Tablet | 01/04/2024 | 521.16 | ||||
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 10 MG 1 package of 28 capsules - Capsule | 50770.90 | 47897.18 | 27535.00 | 01/01/2024 | 2538.55 | |
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 20 MG 1 package of 28 capsules - Capsule | 50770.90 | 47897.18 | 27535.00 | 01/01/2024 | 2538.55 | |
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 30 MG 1 package of 28 capsules - Capsule | 50770.90 | 47897.18 | 28885.00 | 01/01/2024 | 2538.55 | |
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 5 MG 1 package of 28 capsules - Capsule | 50770.90 | 47897.18 | 27535.00 | 01/01/2024 | 2538.55 | |
Rx0000139 | Chiesi USA | 04/08/2024 | Kengreal for injection 50mg/10ML 50mg 1 box of 28 ampules - Solution | 01/01/2024 | 624.39 | ||||
Rx0000139 | Chiesi USA | 04/11/2024 | Myalept Subcutaneous Soltution Reconsituted 11.3 MG 1 vial - Injectable | 5867.52 | 5535.42 | 3493.00 | 01/01/2024 | 293.38 | |
Rx0000139 | Chiesi USA | 04/10/2024 | Mycapssa 20mg 1 package of 28 capsules - Capsule | 3095.49 | 2950.90 | 2576.00 | 01/01/2024 | 154.77 | |
Rx0000139 | Chiesi USA | 04/08/2024 | Revcovi® (elapegademase-IvIr 1.6mg/ml) Injection 1 vial 2.4mg/1.5mL - Solution | 10109.30 | 9856.00 | 9856.00 | 01/04/2024 | 607.26 | |
Rx0000080 | Cipla USA, Inc. | 07/15/2024 | Griseofulvin Oral Suspension USP (microsize) 125mg/5ml, 120ml | 07/15/2024 | 5.02 | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60ml, 10 BOTTLE in 1 CARTON 60 mL in 1 BOTTLE, | 01/01/2024 | 5.00 | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60mL, 120 mL in 1 BOTTLE | 01/01/2024 | 7.52 | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60ml, 473 mL in 1 BOTTLE | 01/01/2024 | 13.48 | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 150mg, 1 box of 60 films | 384.57 | 366.26 | 255.60 | 01/01/2024 | 24.23 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 300mg 1 box of 60 films | 603.98 | 575.22 | 401.40 | 01/01/2024 | 38.05 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 450mg, 1 box of 60 films | 820.66 | 781.58 | 545.40 | 01/01/2024 | 51.70 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 600mg, 1 box of 60 films | 875.70 | 834.00 | 582.00 | 01/01/2024 | 55.17 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 750mg, 1 box of 60 films | 920.85 | 877.00 | 612.00 | 01/01/2024 | 58.01 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 900mg, 1 box of 60 films | 947.93 | 902.79 | 630.00 | 01/01/2024 | 59.72 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca, 75mg, 1 box of 60 films | 384.57 | 366.26 | 255.60 | 01/01/2024 | 24.23 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 100mg, tablet, 100 pack | 1088.71 | 990.64 | 265.00 | 01/01/2024 | 148.48 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 50mg, tablet, 100 pack | 699.13 | 636.15 | 170.00 | 01/01/2024 | 95.35 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 75mg, tablet, 100 pack | 816.86 | 743.28 | 199.00 | 01/01/2024 | 111.41 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 100mg, tablet, 60 pack | 835.46 | 760.20 | 269.40 | 01/01/2024 | 91.06 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 150 mg, tablet, 60 pack | 1077.89 | 980.79 | 346.80 | 01/01/2024 | 117.48 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 200 mg, tablet, 60 pack | 1368.32 | 1245.06 | 441.60 | 01/01/2024 | 149.14 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 250 mg, tablet, 60 pack | 1711.91 | 1557.70 | 441.60 | 01/01/2024 | 186.59 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 50mg, tablet, 60 pack | 451.74 | 411.05 | 145.80 | 01/01/2024 | 49.24 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Symproic 0.2 mg, 1 bottle of 30 tablets | 415.77 | 395.97 | 313.95 | 01/01/2024 | 26.19 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 13.5mg, capsule, 100 pack | 01/01/2024 | 23.77 | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 18mg, capsule, 100 pack | 01/01/2024 | 30.15 | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 27mg, capsule, 100 pack | 01/01/2024 | 41.93 | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 36mg, capsule, 100 pack | 01/01/2024 | 51.62 | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 9mg, capsule, 100 pack | 01/01/2024 | 16.15 | ||||
Rx0000154 | Corcept Therapeutics Incorporated | 04/29/2024 | Korlym (mifepristone) 300mg Tablet (Bottle of 28) | 01/01/2024 | 1678.60 | ||||
Rx0000154 | Corcept Therapeutics Incorporated | 04/29/2024 | Korlym (mifepristone) 300mg Tablet (Bottle of 280) | 01/01/2024 | 16786.00 | ||||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 10 mg/20 mg | 301.20 | 301.20 | 72.30 | 09/20/2024 | 36.34 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 10 mg/40 mg | 380.10 | 380.10 | 91.80 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 5 mg/20 mg | 301.20 | 301.20 | 63.90 | 09/20/2024 | 36.34 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 5 mg/40 mg | 380.10 | 380.10 | 81.00 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 20 mg/12.5 mg | 241.50 | 241.50 | 40.50 | 09/20/2024 | 29.14 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 40 mg/12.5 mg | 335.70 | 335.70 | 40.50 | 09/20/2024 | 40.50 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 40 mg/25 mg | 335.70 | 335.70 | 40.50 | 09/20/2024 | 40.50 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 20 mg | 241.50 | 241.50 | 31.50 | 09/20/2024 | 29.14 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 40 mg | 335.70 | 335.70 | 31.50 | 09/20/2024 | 40.50 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 5 mg | 197.70 | 197.70 | 31.50 | 09/20/2024 | 23.85 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Clomid Tablets 50 mg 30-ct box | 56.00 | 56.00 | 118.50 | 02/01/2024 | 19.31 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Clomid Tablets 50 ng 10-ct box | 20.00 | 20.00 | 25.00 | 02/01/2024 | 6.49 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Effient Tablets 10 mg | 459.00 | 459.00 | 191.40 | 09/20/2024 | 55.38 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Effient Tablets 5 mg | 459.00 | 459.00 | 191.40 | 09/20/2024 | 55.38 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Migergot Suppositories 2-100 mg 12-ct box | 02/01/2024 | 223.87 | ||||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 20 mg/5 mg/12.5 mg | 301.20 | 301.20 | 84.90 | 09/20/2024 | 36.34 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/10 mg/12.5 mg | 380.10 | 380.10 | 107.40 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/10 mg/25 mg | 380.10 | 380.10 | 107.40 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/5 mg/12.5 mg | 380.10 | 380.10 | 107.40 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/5 mg/25 mg | 380.10 | 380.10 | 107.40 | 09/20/2024 | 45.86 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Welchol for Oral Suspension 3.75 g | 669.60 | 669.60 | 193.20 | 09/20/2024 | 80.79 | |
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Welchol Tablets 625 mg | 669.60 | 669.60 | 113.40 | 09/20/2024 | 80.79 | |
Rx0000425 | CSL Behring LLC | 04/10/2024 | Berinert 500 units (500 IU / Solution / Pkg Size 1) | 01/01/2024 | 217.24 | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Berinert 500 units (500 IU / Solution / Pkg Size 1) | 07/01/2024 | 230.27 | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Haegarda 2000iu / 2000iu Solution / UOM EA = 1 vial | 07/01/2024 | 126.78 | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Haegarda 3000iu / 3000iu Solution / UOM EA = 1 vial | 07/01/2024 | 190.17 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) - inner / 2gm Solution / UOM EA = 1 vial | 07/01/2024 | 14.96 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) PFS - inner / 2gm Solution / UOM EA = 1 vial | 07/01/2024 | 14.96 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) PFS / 2gm Solution / UOM EA = 1 vial | 07/01/2024 | 14.96 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) / 2gm Solution / UOM EA = 1 vial | 07/01/2024 | 14.96 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) - inner / 4gm Solution / UOM EA = 1 vial | 07/01/2024 | 29.92 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) PFS - inner / 4gm Solution / UOM EA = 1 vial | 07/01/2024 | 29.92 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) PFS / 4gm Solution / UOM EA = 1 vial | 07/01/2024 | 29.92 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) / 4gm Solution / UOM EA = 1 vial | 07/01/2024 | 29.92 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) - inner / 1gm Solution / UOM EA = 1 vial | 07/01/2024 | 7.48 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) / 1gm Solution / UOM EA = 1 vial | 07/01/2024 | 7.48 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) PFS - inner / 1gm Solution / UOM EA = 1 vial | 07/01/2024 | 7.48 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) PFS / 1gm Solution / UOM EA = 1 vial | 07/01/2024 | 7.48 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) - inner / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 74.80 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 74.80 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) PFS - inner / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 74.80 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) PFS / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 74.80 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 100ml (10g) - Inner / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 51.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 100ml (10g) / 10gm Solution / UOM EA = 1 vial | 07/01/2024 | 51.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 200ml (20g) - Inner / 20gm Solution / UOM EA = 1 vial | 07/01/2024 | 102.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 200ml (20g) / 20gm Solution / UOM EA = 1 vial | 07/01/2024 | 102.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 400ml (40g) - Inner / 40gm Solution / UOM EA = 1 vial | 07/01/2024 | 204.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 400ml (40g) / 40gm Solution / UOM EA = 1 vial | 07/01/2024 | 204.00 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 50ml (5g) - Inner / 5gm Solution / UOM EA = 1 vial | 07/01/2024 | 25.50 | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 50ml (5g) / 5gm Solution / UOM EA = 1 vial | 07/01/2024 | 25.50 | ||||
Rx0000230 | Cumberland Pharmaceuticals | 05/01/2024 | CALDOLOR VIALS 25 5mL VIA. | 01/03/2024 | 17.32 | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | KRISTALOSE 10GM SOLD BY CASE (30 PACKETS) | 06/28/2024 | 8.31 | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | KRISTALOSE 20GM SOLD BY CASE (30 PACKETS) | 06/28/2024 | 8.61 | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | VIBATIV 750MG CASE OF 12 SINGLE DOSE VIALS | 06/28/2024 | 220.70 | ||||
Rx0000216 | Deciphera Pharmaceuticals, LLC | 04/29/2024 | Qinlock Oral Tablet 50 MG, 90 Each, Bottle | 01/01/2024 | 1980.00 | ||||
Rx0000216 | Deciphera Pharmaceuticals, LLC | 10/03/2024 | Qinlock Oral Tablet 50 MG, 90 Each, Bottle | 07/01/2024 | 900.00 | ||||
Rx0000492 | Dynavax Technologies Corporation | 03/31/2024 | HEPLISAV-B [Hepatitis B Vaccine (Recombinant)] Adjuvanted 20 MCG / 0.5 ML PFS Injection, Solution 5 SYRINGE in 1 CARTON (43528-003-05) / .5 mL in 1 SYRINGE (43528-003-01) | 03/01/2024 | 35.15 | ||||
Rx0000282 | Edenbridge Pharmaceuticals, LLC | 07/03/2024 | METHENAMINE MANDELATE - 0.5g Oral Tablet, 100ct Bottle [Qty: 1] | 07/01/2024 | 76.14 | ||||
Rx0000282 | Edenbridge Pharmaceuticals, LLC | 07/03/2024 | METHENAMINE MANDELATE -1g Oral Tablet, 100ct Bottle [Qty: 1] | 07/01/2024 | 161.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 & 4 MG Capsule Therapy Pack 10 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 MG & 2 x 4 MG Capsule Therapy Pack 15 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 MG Capsule Therapy Pack 5 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 10 MG & 4 MG Capsule Therapy Pack 15 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 10 MG Capsule Therapy Pack 10 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 4 MG Capsule Therapy Pack 10 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 3 x 4 MG Capsule Therapy Pack 15 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 3 x 4 MG Capsule Therapy Pack 90 EA UU | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 4 MG Capsule Therapy Pack 30 EA UU | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 4 MG Capsule Therapy Pack 5 EA UU | 01/22/2024 | 135.17 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate) 8 mg/day (4 mg x 2) 60 count | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate)10 mg/day (10 mg x 1) 30 count | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate)14 mg/day (10 mg x 1 and 4 mg x 1) 60 count | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 18 mg/day (10 mg x 1 and 4 mg x 2) 30 day supply | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 20 mg/day (10 mg x 2) 30 day supply | 01/22/2024 | 811.00 | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 24 mg/day (10 mg x 2 and 4 mg x 1) 30 day supply | 01/22/2024 | 811.00 | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 100 mg Dosage Form: TABLET | 01/01/2024 | 218.01 | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 150 mg Dosage Form: TABLET | 01/01/2024 | 218.01 | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 200 mg Dosage Form: TABLET | 01/01/2024 | 218.01 | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 50 mg Dosage Form: TABLET | 01/01/2024 | 218.01 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Cetrotide Subcutaneous Kit 0.25 MG, 1 Each, Box | 01/29/2024 | 14.34 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (10 Tabs) Oral Tablet Therapy Pack 10 MG, 10 Each, Unit-of-Use, Box | 04/09/2024 | 5797.40 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (4 Tabs) Oral Tablet Therapy Pack 10 MG, 4 Each, Unit-of-Use, Box | 04/09/2024 | 2318.96 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (5 Tabs) Oral Tablet Therapy Pack 10 MG, 5 Each, Unit-of-Use, Box | 04/09/2024 | 2898.70 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (6 Tabs) Oral Tablet Therapy Pack 10 MG, 6 Each, Unit-of-Use, Box | 04/09/2024 | 3478.44 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (7 Tabs) Oral Tablet Therapy Pack 10 MG, 7 Each, Unit-of-Use, Box | 04/09/2024 | 4058.18 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (8 Tabs) Oral Tablet Therapy Pack 10 MG, 8 Each, Unit-of-Use, Box | 04/09/2024 | 4637.92 | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (9 Tabs) Oral Tablet Therapy Pack 10 MG, 9 Each, Unit-of-Use, Box | 04/09/2024 | 5217.66 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Ovidrel Subcutaneous Injectable 250 MCG/0.5ML, .5 ML, Unit-Dose, Syringe | 01/29/2024 | 16.34 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Subcutaneous Solution Auto-injector 22 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Subcutaneous Solution Auto-injector 44 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Titration Pack Subcutaneous Solution Auto-injector 6X8.8 & 6X22 MCG, 4.2 ML, Unit-of-Use, Box | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Subcutaneous Solution Prefilled Syringe 22 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Subcutaneous Solution Prefilled Syringe 44 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Titration Pack Subcutaneous Solution Prefilled Syringe 6X8.8 & 6X22 MCG, 4.2 ML, Unit-of-Use, Box | 01/29/2024 | 644.85 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 4 MG, 1 Each, Unit-Dose, Vial Qty 7 | 01/29/2024 | 177.52 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 5 MG, 1 Each, Unit-Dose, Vial Qty 7 | 01/29/2024 | 221.90 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 6 MG, 1 Each, Unit-Dose, Vial Qty 7 | 01/29/2024 | 266.28 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Tepmetko Oral Tablet 225 MG, 30 Each, Box | 01/09/2024 | 636.60 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Tepmetko Oral Tablet 225 MG, 60 Each, Box | 01/09/2024 | 1273.20 | ||||
Rx0000557 | Emmaus Medical, Inc. | 03/31/2024 | ENDARI [L-glutamine oral powder], 5g/1, Powder for solution, 1 powder for solution in 1 packet | 03/01/2024 | 1.54 | ||||
Rx0000557 | Emmaus Medical, Inc. | 03/31/2024 | ENDARI [L-glutamine oral powder], 5g/1, Powder for solution, 60 packet in 1 carton | 03/01/2024 | 92.93 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Aveed, 750 mg/3mL (250mg/1mL) solution, single use vial | 04/01/2024 | 88.06 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 10 MCG, 2 | 01/01/2024 | 9.65 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 10 MCG, 6 | 01/01/2024 | 28.96 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 20 MCG, 2 | 01/01/2024 | 12.47 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 20 MCG, 6 | 01/01/2024 | 37.41 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 40 MCG, 2 | 01/01/2024 | 17.03 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 40 MCG, 6 | 01/01/2024 | 51.08 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | FROVA®, Frovatriptan Succinate Tab 2.5 MG (Base Equivalent), 9 | 01/01/2024 | 115.59 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 10-325 MG, 100 | 01/01/2024 | 338.24 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 2.5-325 MG, 100 | 01/01/2024 | 171.07 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 5-325 MG, 100 | 01/01/2024 | 239.43 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 5-325 MG, 500 | 01/01/2024 | 1167.04 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 7.5-325 MG, 100 | 01/01/2024 | 258.67 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 100 MG, 100 | 01/01/2024 | 31.71 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 200 MG, 100 | 01/01/2024 | 47.13 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 300 MG, 100 | 01/01/2024 | 57.93 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 400 MG, 100 | 01/01/2024 | 81.52 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Valstar, 40 mg/1ml solution, 4x5mL | 04/01/2024 | 257.51 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Xiaflex, 0.9mg powder for solution, single use vial | 04/01/2024 | 247.15 | ||||
Rx0000584 | Endo USA, Inc. | 07/31/2024 | BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE 500MG/VIAL | 92.36 | 81.83 | 38.58 | 05/06/2024 | 4.62 | |
Rx0000584 | Endo USA, Inc. | 07/31/2024 | TIGAN TRIMETHOBENZAMIDE HYDROCHLORIDE INJECTABLE 100MG/ML, 25vl | 1255.18 | 1112.01 | 164.78 | 05/06/2024 | 62.76 | |
Rx0000405 | Esperion | 03/31/2024 | Nexletol 30 Tab 180 mg/1 Tablet Film Coated | 01/01/2024 | 11.88 | ||||
Rx0000405 | Esperion | 03/31/2024 | Nexlizet 30 Tab 180 mg/1, 10 mg/1 Tablet Film Coated | 01/01/2024 | 11.88 | ||||
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 MG, 50 Capsules, Bottle | 349.32 | 349.32 | 349.32 | 01/10/2024 | 39.59 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 1 MG, 50 Capsules, Bottle | 698.64 | 698.64 | 698.64 | 01/10/2024 | 79.18 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 2 MG, 50 Capsules, Bottle | 1397.28 | 1397.28 | 1397.28 | 01/10/2024 | 158.36 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 5 MG, 50 Capsules, Bottle | 3493.20 | 3493.20 | 3493.20 | 01/10/2024 | 395.80 | |
Rx0000455 | Evofem Biosciences, Inc. | 04/30/2024 | Phexxi Vaginal Gel 1.8-1-0.4%, 5 GM, Unit-of-Use, Box Qty 12 | 01/01/2024 | 10.14 | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 20MG 30 TAB BTL EACH | 01/01/2024 | 550.75 | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 40MG 30 TAB BTL EACH | 01/01/2024 | 550.75 | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 60MG 30 TAB BTL EACH | 01/01/2024 | 550.75 | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | NALOCET TABLETS 1 PACK 100 TABS 2.5 MG/300 MG | 04/01/2024 | 111.04 | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 10 MG/300 MG | 04/01/2024 | 111.04 | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 5 MG/300 MG | 04/01/2024 | 111.04 | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 7.5 MG/300 MG | 04/01/2024 | 111.04 | ||||
Rx0000260 | Galderma Laboratories | 04/10/2024 | TRI-LUMA Cream 24x30g US | 01/01/2024 | 11.68 | ||||
Rx0000034 | Genentech USA | 04/25/2024 | Alecensa 150 Mg - 240 Capsules | 01/01/2024 | 1049.37 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | ENSPRYNG® (satralizumab-mwge) 120 mg/mL prefilled syringe | 01/01/2024 | 660.62 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | GAZYVA® (obinutuzumab) 1,000 mg/40 mL vial | 01/01/2024 | 466.52 | ||||
Rx0000034 | Genentech USA | 07/24/2024 | KADCYLA® (ado-trastuzumab emtansine) 100 mg vial. Lyophilized powder in single-dose vials: 100 mg per vial of ado-trastuzumab emtansine. | 07/01/2024 | 38.92 | ||||
Rx0000034 | Genentech USA | 07/24/2024 | KADCYLA® (ado-trastuzumab emtansine) 160 mg vial. Lyophilized powder in single-dose vials: 160 mg per vial of ado-trastuzumab emtansine. | 07/01/2024 | 62.27 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | KADCYLA® (ado-trastuzumab emtansine) 100 mg vial | 01/01/2024 | 149.68 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | KADCYLA® (ado-trastuzumab emtansine) 160 mg vial | 01/01/2024 | 239.49 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | PERJETA® (pertuzumab) 420 mg/14 mL vial | 01/01/2024 | 190.10 | ||||
Rx0000034 | Genentech USA | 07/24/2024 | POLIVY® (polatuzumab vedotin-piiq) 140 mg Vial. POLIVY for injection is a sterile, preservative-free, white to grayish-white lyophilized powder, which has a cake-like appearance and is supplied in 140 mg single-dose vial. | 07/01/2024 | 526.29 | ||||
Rx0000034 | Genentech USA | 07/24/2024 | POLIVY® (polatuzumab vedotin-piiq) 30 mg vial. POLIVY for injection is a sterile, preservative-free, white to grayish-white lyophilized powder, which has a cake-like appearance and is supplied in a 30 mg single-dose vial. | 07/01/2024 | 112.78 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | POLIVY® (polatuzumab vedotin-piiq) 30 mg vial | 01/01/2024 | 212.79 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | POLIVY® (polatuzumab vidotin-piiq) 140 mg vial | 01/01/2024 | 993.00 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | TNKase® (tenecteplase) 50 mg vial | 01/01/2024 | 221.35 | ||||
Rx0000034 | Genentech USA | 07/24/2024 | TNKase® (tenecteplase) 50 mg vial. TNKase (tenecteplase for injection) is supplied as a sterile, lyophilized powder in a 50 mg, glass (20 cc) vial under partial vacuum. | 07/01/2024 | 227.99 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 150 mg vial | 01/01/2024 | 78.39 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 150 mg/mL syringe | 01/01/2024 | 78.39 | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 75 mg/0.5 mL syringe | 01/01/2024 | 39.20 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 30 mg-120 mg-15 mg) tablet, 30ct bottle | 01/01/2024 | 185.97 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 50 mg-200 mg-25 mg) tablet, 30ct blister pack | 01/01/2024 | 185.97 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 50 mg-200 mg-25 mg) tablet, 30ct bottle | 01/01/2024 | 185.97 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | CAYSTON (aztreonam for inhalation solution) 75mg/vial, 84 vials/kit | 01/01/2024 | 559.44 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | COMPLERA (emtricitabine/rilpivirine HCl/tenofovir disoproxil fumarate 200 mg-25 mg-300 mg) tablet, 30ct bottle | 01/01/2024 | 169.24 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | GENVOYA (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide 150 mg-150 mg-200 mg-10 mg) tablet, 30ct bottle | 01/01/2024 | 185.97 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 10 mg) tablet, 10ct bottle | 01/01/2024 | 202.11 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 10 mg) tablet, 30ct bottle | 01/01/2024 | 606.34 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 5 mg) tablet, 10ct bottle | 01/01/2024 | 202.11 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 5 mg) tablet, 30ct bottle | 01/01/2024 | 606.34 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ODEFSEY (emtricitabine/rilpivirine HCl/tenofovir alafenamide fumarate 200 mg-25 mg-25 mg) tablet, 30ct bottle | 01/01/2024 | 169.24 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil 150 mg-150 mg-200 mg-300 mg) tablet, 30ct bottle | 01/01/2024 | 195.07 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | TYBOST (cobicistat 150 mg) tablet, 30ct bottle | 01/01/2024 | 13.89 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | VEMLIDY (tenofovir alafenamide 25mg) tablets, 30ct bottle | 01/01/2024 | 67.34 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ZYDELIG (idelalisib 100 mg) tablet, 60ct bottle | 01/01/2024 | 645.00 | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ZYDELIG (idelalisib 150 mg) tablet, 60ct bottle | 01/01/2024 | 645.00 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Auto-injector 1 ML | 01/01/2024 | 57.65 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Auto-injector 1 ML X4 | 01/01/2024 | 230.60 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Prefilled Syringe 1 ML UD | 01/01/2024 | 57.65 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Prefilled Syringe 1 ML UD X4 | 01/01/2024 | 230.60 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Bexsero, Meningococcal Vac Group B (Recombant OMV Adjuvanted) Suspension Prefilled Syringe 0.5 ML UD | 01/01/2024 | 12.43 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Bexsero, Meningococcal Vac Group B (Recombant OMV Adjuvanted) Suspension Prefilled Syringe 0.5 ML UD X10 | 01/01/2024 | 124.24 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Nucala, Mepolizumab 100 MG/ML Solution Auto-injector 1 ML UD | 01/01/2024 | 107.44 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Nucala, Mepolizumab 100 MG/ML Solution Prefilled Syringe 1 ML UD | 01/01/2024 | 107.44 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Shingrix, Zoster Vaccine Recombinant Adjuvanted 50 MCG/0.5ML Suspension Reconstituted 1 EA UD | 01/01/2024 | 14.49 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Shingrix, Zoster Vaccine Recombinant Adjuvanted 50 MCG/0.5ML Suspension Reconstituted 1 EA UD X10 | 01/01/2024 | 144.89 | ||||
Rx0000164 | Harmony Biosciences, LLC | 04/24/2024 | WAKIX pitolisant HCl 17.8 mg 30 Oral Tab | 01/02/2024 | 509.69 | ||||
Rx0000164 | Harmony Biosciences, LLC | 04/24/2024 | WAKIX pitolisant HCl 4.45 mg 30 Oral Tab | 01/02/2024 | 254.84 | ||||
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Ilevro Ophthalmic Suspension 0.3 % | 362.09 | 329.47 | 200.00 | 01/19/2024 | 18.10 | |
Rx0000534 | Harrow Eye, LLC | 07/18/2024 | Natamycin Ophth Susp 5%, 15 ML, Unit-of-Use, Bottle | 473.64 | 473.64 | 75.00 | 05/03/2024 | 473.36 | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Nevanac Ophthalmic Suspension 0.1 % | 313.45 | 285.21 | 63.00 | 01/19/2024 | 15.67 | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Triesence Intraocular Suspension 40 MG/ML | 161.09 | 157.93 | 124.00 | 02/02/2024 | 782.91 | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Verkazia Ophthalmic Emulsion 0.1 % | 1465.00 | 1465.00 | 1465.00 | 01/19/2024 | 366.25 | |
Rx0000145 | Horizon Therapeutics USA, Inc. | 07/22/2024 | Product Name: KRYSTEXXA; Drug product strength: 1 mL sterile concentrate for dilution containing 8 mg of pegloticase protein, expressed in uricase protein amounts. Drug product dosage form: vial. Drug product package size: 8 MG/ML single use vial | 06/27/2024 | 687.20 | ||||
Rx0000287 | Insmed Incorporated | 04/12/2024 | Arikayce Inhalation Suspension 590 MG/8.4ML | 01/01/2024 | 866.52 | ||||
Rx0000266 | Intercept Pharmaceuticals, Inc. | 04/02/2024 | Ocaliva - OBETICHOLIC ACID - 10mg Oral Tablet, 30ct bottle [Qty:1] | 04/02/2024 | 532.28 | ||||
Rx0000266 | Intercept Pharmaceuticals, Inc. | 04/02/2024 | Ocaliva - OBETICHOLIC ACID - 5mg Oral Tablet, 30ct bottle [Qty:1] | 04/02/2024 | 532.28 | ||||
Rx0000214 | Intra-Cellular Therapies, Inc. | 04/02/2024 | Caplyta Oral Capsule 42 MG 30 Pack | 01/01/2024 | 92.58 | ||||
Rx0000084 | Ipsen Biopharmaceuticals, Inc. | 10/02/2024 | Drug product name: Onivyde. Drug product strength: 43 mg/10 mL (4.3 mg/mL). Drug product dosage form: vial. Drug product package size: 10 mL. | 10/01/2024 | 71.00 | ||||
Rx0000084 | Ipsen Biopharmaceuticals, Inc. | 03/31/2024 | Drug product name: Tazverik. Drug product strength: 200mg. Drug product dosage form: tablet. Drug product package size: 1 bottle (240 tablets). | 17746.00 | 16585.00 | 15500.00 | 02/15/2024 | 1320.00 | |
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)Strength: 1800mg / 15 mL Package Size:1 Form:1 single vial | 01/24/2024 | 574.47 | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)Strength: 1800mg / 15 mL Package Size:1 Form:1 single vial | 09/17/2024 | 329.56 | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX (daratumumab)Strength:100 mg 5 mL Package Size:1 Form:1 single vial | 01/24/2024 | 42.15 | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX (daratumumab)Strength:100 mg 5 mL Package Size:1 Form:1 single vial | 09/17/2024 | 24.18 | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX (daratumumab)Strength:400 mg 20 mL Package Size:1 Form:1 single vial | 01/24/2024 | 168.59 | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX (daratumumab)Strength:400 mg 20 mL Package Size:1 Form:1 single vial | 09/17/2024 | 96.72 | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | RYBREVANT (amivantamab-vmjw)Strength: 350mg/7mL Package Size:1 Form:1 single vial | 01/24/2024 | 133.95 | ||||
Rx0000248 | Janssen Biotech, Inc. | 07/30/2024 | RYBREVANT (amivantamab-vmjw)Strength: 350mg/7mL Package Size:1 Form:1 single vial | 06/28/2024 | 163.69 | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | TREMFYA (guselkumab) One Press Injector Strength: 100mg / 1 mL Package Size:1 Form:1 syringe | 01/24/2024 | 660.61 | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | TREMFYA (guselkumab) prefilled syringe Strength: 100mg / 1 mL Package Size:1 Form:1 syringe | 01/24/2024 | 660.61 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | ELMIRON® Strength:100 mg Package Size:100 Form:Capsule | 01/24/2024 | 38.20 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® HAFYERA® Strength:1092 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 637.25 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® HAFYERA® Strength:1560 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 955.79 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:117 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 65.29 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:156 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 87.05 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:234 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 130.58 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:39 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 21.76 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:78 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 43.52 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:273 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 130.57 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:410 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 195.88 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:546 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 261.16 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:819 mg Package Size:1 Form:Disposable Syringe/Dose Pack | 01/24/2024 | 391.72 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 07/30/2024 | PONVORY ® (ponesimod) Strength: 10 mg Package Size:14 Form:Tablet | 04/09/2024 | 212.72 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 07/30/2024 | PONVORY ® (ponesimod) Strength: 20 mg Package Size:30 Form:Tablet | 04/09/2024 | 455.82 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | SPRAVATO Strength:56 mg Package Size:2 Form:Nasal Spray | 01/24/2024 | 36.78 | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | SPRAVATO Strength:84 mg Package Size:3 Form:Nasal Spray | 01/24/2024 | 55.18 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:3 MG Package Size:56 Form:Tablet | 01/24/2024 | 1394.20 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:3 MG Package Size:84 Form:Tablet | 01/24/2024 | 2091.31 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:4 MG Package Size:28 Form:Tablet | 01/24/2024 | 929.47 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:4 MG Package Size:56 Form:Tablet | 01/24/2024 | 1858.94 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:5 MG Package Size:28 Form:Tablet | 01/24/2024 | 1161.84 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | EDURANT (rilpivirine) Strength:25mg Package Size:30 Form:Tablet | 01/24/2024 | 102.62 | ||||
Rx0000250 | Janssen Products, LP | 07/30/2024 | EDURANT (rilpivirine) Strength:25mg Package Size:30 Form:Tablet | 06/28/2024 | 30.51 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | ERLEADA (apalutamide) Strength:60mg Package Size:120 Form:Tablet | 01/24/2024 | 710.13 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZCOBIX (darunavir 800mg, cobicistat 150mg) Strength:800 MG/150 MG Package Size:30 Form:Tablet | 01/24/2024 | 71.85 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:150 MG Package Size:240 Form:Tablet | 01/24/2024 | 62.86 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:600 MG Package Size:60 Form:Tablet | 01/24/2024 | 62.86 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:75 MG Package Size:480 Form:Tablet | 01/24/2024 | 62.86 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:800 MG Package Size:30 Form:Tablet | 01/24/2024 | 62.86 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® ORAL SUSPENSION Strength:100MG/mL Package Size:200mL Form:Oral Suspension | 01/24/2024 | 34.92 | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | SYMTUZA (darunavir 800mg/cobicistat 150mg/emtricitabine 200mg/tenofovir alafenamide 10mg) Strength: 800 MG/150 MG/200 MG/10 MG Package Size:30 Form:Tablet | 01/24/2024 | 124.01 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Defitelio (Defibrotide Sodium) Carton of 10 Vials | 07/15/2024 | 280.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Defitelio 200mg/2.5mL Solution 80mg/1mL | 01/12/2024 | 400.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | RYLAZE (asparaginase erwinia chrysanthemi (recombinant)-rywn) injection - 3 vial pack | 07/15/2024 | 450.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Vyxeos daunorubicin and cytarabine liposome for injection (2 vial carton) | 07/15/2024 | 510.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Xyrem 500 MG/ML Oral Solution 180 ml | 01/12/2024 | 320.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Xywav 500 MG/ML Oral Solution 180 ml | 01/12/2024 | 460.00 | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Zepzelca (lurbinectedin) 4mg Vial | 6633.00 | 6633.00 | 07/15/2024 | 80.00 | ||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (100 MG Once Weekly) Oral Tablet Therapy Pack 50 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (40 MG Once Weekly) Oral Tablet Therapy Pack 40 MG, 1 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (40 MG Twice Weekly) Oral Tablet Therapy Pack 40 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (60 MG Once Weekly) Oral Tablet Therapy Pack 60 MG, 1 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (60 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG, 6 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (80 MG Once Weekly) Oral Tablet Therapy Pack 40 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (80 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG, 8 Each, Unit-of-Use, Disp Pack Qty 4 | 01/01/2024 | 2763.00 | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 100ml vial | 01/01/2024 | 84.51 | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 200ml vial | 01/01/2024 | 169.03 | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 50ml vial | 01/01/2024 | 42.26 | ||||
Rx0000386 | KVK Tech, Inc. | 04/09/2024 | Lomaira Oral Tablet 8 MG 90ct | 01/01/2024 | 1.77 | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 10 mg/mL, 1 ML, single dose vial | 01/08/2024 | 211.97 | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 20 mg/mL, 1 ML, single dose vial | 01/08/2024 | 423.95 | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 30 mg/mL, 1 ML, single dose vial | 01/08/2024 | 635.92 | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | Nourianz Oral Tablet 20 MG, 90 Each, Bottle | 01/05/2024 | 270.39 | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | Nourianz Oral Tablet 40 MG, 90 Each, Bottle | 01/05/2024 | 270.39 | ||||
Rx0000083 | Laboratoire HRA Pharma | 06/17/2024 | Lysodren 500 mg tablets 100 count bottles | 04/01/2024 | 128.05 | ||||
Rx0000083 | Laboratoire HRA Pharma | 06/17/2024 | Metopirone 250 mg capsules 18 count bottles | 04/01/2024 | 83.25 | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 40mg Capsule 100 CT Bottle | 08/17/2024 | 265.34 | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 50mg Capsule 100 CT Bottle | 07/25/2024 | 265.34 | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 60mg Capsule 100 CT Bottle | 08/16/2024 | 265.34 | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 70mg Capsule 100 CT Bottle | 08/16/2024 | 265.34 | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | DEFINITY US 16Vial KIT. INJECTION, SUSPENSION, 6.52 mg/mL. 16 VIAL, GLASS in 1 CARTON (11994-011-16) > 1.5 mL in 1 VIAL, GLASS | 01/01/2024 | 303.71 | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | DEFINITY US 4Vial KIT. INJECTION, SUSPENSION, 6.52 mg/mL. 4 VIAL, GLASS in 1 CARTON (11994-011-04) > 1.5 mL in 1 VIAL, GLASS | 01/01/2024 | 78.72 | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) | 01/01/2024 | 587.81 | ||||
Rx0000413 | Leadiant Biosciences, Inc. | 04/29/2024 | Cystaran Ophthalmic Solution 0.44 % | 01/01/2024 | 67.36 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 100mg. 90 Capsules | 01/02/2024 | 123.60 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 200mg. 90 Capsules | 01/02/2024 | 247.20 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 300mg. 90 Capsules | 01/02/2024 | 370.80 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi 10mg. 100 Tablets | 01/02/2024 | 233.58 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi 20mg. 100 Tablets | 01/02/2024 | 467.16 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi Oral Suspension 2.5mg/mL 120mL Bottle | 01/02/2024 | 122.73 | ||||
Rx0000025 | Lundbeck LLC | 10/24/2024 | Vyepti 100mg/ml single dose vial | 07/01/2024 | 60.10 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Xenazine 12.5mg. 112 Tablets | 01/02/2024 | 1012.80 | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Xenazine 25.0mg. 112 Tablets | 01/02/2024 | 2025.60 | ||||
Rx0000072 | Mayne Pharma Inc | 07/26/2024 | Rhofade External Cream 1 %, 30 g, Unit-of-Use, Tube | 568.00 | 568.00 | 520.13 | 06/01/2024 | 55.72 | |
Rx0000382 | Melinta Therapeutics, LLC | 04/30/2024 | MINOCIN (Minocycline-Hydrochloride) is administered via intravenous form and packaged as 10 VIAL in 1 CARTON > 1 INJECTION in 1 VIAL (100 mg dose) | 01/01/2024 | 119.00 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | BRIDION 10 200 mg/2 mL Vial (ML) | 01/06/2024 | 61.60 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | BRIDION 10 500 mg/5 mL Vial (ML) | 01/06/2024 | 113.00 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | DIFICID 1 packet granules (40mg/mL final concentration) Suspension-Reconsitituted-Oral (EA) | 01/06/2024 | 282.00 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | DIFICID 20 200 mg Tablets | 01/06/2024 | 282.00 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | GARDASIL 9 0.5 mL Syringes 10 | 08/12/2024 | 200.75 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | GARDASIL 9 0.5 mL Vials 10 | 08/12/2024 | 200.75 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | VARIVAX 0.5 mL Vials 10 | 08/12/2024 | 86.79 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | ZERBAXA 10 1.5 gram Vial (EA) | 01/06/2024 | 142.90 | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Femring (estradiol acetate vaginal ring) 0.1 mg/day, 1 Box | 01/01/2024 | 69.03 | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Femring (estradiol acetate vaginal ring) 0.05 mg/day, 1 Box | 01/01/2024 | 64.78 | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Intrarosa Prasterone Vaginal Inserts 6.5 mg per insert, 28 inserts per box | 212.30 | 202.00 | 175.00 | 01/01/2024 | 16.03 | |
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Cimduo Tabs 300mg/300mg 30s | 01/30/2024 | 56.43 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Depen (Penicillamine Tabs) 250mg 1s | 01/30/2024 | 360.14 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 10mg Sublingual T 3x10 | 01/30/2024 | 20.99 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 10mg Sublingual T 5x6 | 01/30/2024 | 20.99 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 5mg Sublingual T 3x10 | 01/30/2024 | 20.99 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 5mg Sublingual T 5x6 | 01/30/2024 | 20.99 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 12mg/day Bx30 | 01/30/2024 | 102.14 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 6mg/day Bx30 | 01/30/2024 | 102.14 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 9mg/day Bx30 | 01/30/2024 | 102.14 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Epifoam 1% 10g 1PK | 01/30/2024 | 4.54 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Gastrocrom Oral Concentrate 20mg/mL 5mL 96s | 01/30/2024 | 52.98 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Levsin Tabs 0.125mg 100s | 01/30/2024 | 13.42 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Levsin/SL Tabs 0.125mg 100s | 01/30/2024 | 13.42 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | NuLev Chewable Melt Tabs 0.125mg 100s | 01/30/2024 | 10.56 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Pretomanid Tabs 200mg 26s | 01/30/2024 | 28.86 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Proctofoam HC 1% 10g 1PK | 01/30/2024 | 8.82 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Proctofoam NS 1% 15g | 01/30/2024 | 4.37 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Rowasa Kit Rectal Suspension 4g/60mL 28PK | 01/30/2024 | 84.68 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Rowasa Kit Rectal Suspension 4g/60mL 7PK | 01/30/2024 | 22.28 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 250mg 30s | 01/30/2024 | 10.49 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 250mg100s | 01/30/2024 | 34.97 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 350mg 100s | 01/30/2024 | 51.00 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Symfi Lo Tabs 400mg/300mg/300mg 30s | 01/30/2024 | 91.73 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Symfi Tabs 600mg/300mg/300mg 30s | 01/30/2024 | 91.73 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Tobramycin Inhalation Solution (Tobi) 300mg/5mL 56s | 01/30/2024 | 411.81 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Urelle Tabs 0.12mg/81mg/10.8mg/32.4mg/40.8mg 90s | 01/30/2024 | 38.40 | ||||
Rx0000046 | Mylan Specialty LP | 10/31/2024 | YUPELRI (Revefenacin) Inhalation Solution 175mcg/3mL 30PK | 07/02/2024 | 135.25 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | YUPELRI Inhalation Solution 175mcg/3mL | 01/30/2024 | 65.06 | ||||
Rx0000476 | Neurelis | 03/31/2024 | 1 VALTOCO CARTON .5mg/.1ml VIAL, 1 Each, Unit-of-Use, Box Qty 2 | 01/01/2024 | 36.34 | ||||
Rx0000476 | Neurelis | 03/31/2024 | 1 VALTOCO CARTON 10mg/.1ml VIAL, 1 Each, Unit-of-Use, Box Qty 2 | 01/01/2024 | 36.34 | ||||
Rx0000476 | Neurelis | 03/31/2024 | VALTOCO CARTON with 10mg/.1ml VIALS, 1 Each, Unit-of-Use, Box Qty 2 | 01/01/2024 | 36.34 | ||||
Rx0000476 | Neurelis | 03/31/2024 | VALTOCO CARTON with 7.5mg/.1ml VIALS, 1 Each, Unit-of-Use, Box Qty 2 | 01/01/2024 | 36.34 | ||||
Rx0000420 | Nielsen BioSciences, Inc. | 03/31/2024 | Candin Injection Solution/1U in 0.1mL Intradermally/1mL Vial | 01/01/2024 | 24.00 | ||||
Rx0000420 | Nielsen BioSciences, Inc. | 03/31/2024 | Spherusol Injection Solution/Coccidioides immitis Spherule-Derived Skin Test Antigen - 1.27mcg/0.1mL/1mL Vial/0.1mL Intradermally/1ml multidose vial | 01/01/2024 | 94.00 | ||||
Rx0000204 | Noden Pharma USA, Inc. | 03/31/2024 | TEKTURNA 150MG TAB 30/EA | 01/15/2024 | 26.15 | ||||
Rx0000204 | Noden Pharma USA, Inc. | 03/31/2024 | TEKTURNA 300MG TAB 30/EA | 01/15/2024 | 33.00 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 2 mg 28 | 01/10/2024 | 517.25 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 3 mg 28 | 01/10/2024 | 522.43 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 5 mg 28 | 01/10/2024 | 543.74 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 10 mg 28 | 01/10/2024 | 543.74 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 2.5 mg 28 | 01/10/2024 | 519.84 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 5 mg 28 | 01/10/2024 | 543.74 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 7.5 mg 28 | 01/10/2024 | 543.74 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX (2 SYRINGES) SYRINGE (ML) 150 mg/mL 1 | 01/10/2024 | 484.70 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SENSOREADY (2 PENS) PEN INJECTOR (ML) 150 mg/mL 1 | 01/10/2024 | 484.70 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SENSOREADY PEN PEN INJECTOR (ML) 150 mg/mL 1 | 01/10/2024 | 484.70 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SYRINGE SYRINGE (ML) 150 mg/mL 1 | 01/10/2024 | 484.70 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SYRINGE SYRINGE (ML) 75 mg/0.5 mL 0.5 | 01/10/2024 | 242.35 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 160 mg-12.5 mg 90 | 01/10/2024 | 19.96 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 160 mg-25 mg 90 | 01/10/2024 | 22.64 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 320 mg-12.5 mg 90 | 01/10/2024 | 25.29 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 320 mg-25 mg 90 | 01/10/2024 | 28.69 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 80 mg-12.5 mg 90 | 01/10/2024 | 18.35 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 160 mg 90 | 01/10/2024 | 17.54 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 320 mg 90 | 01/10/2024 | 22.19 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 40 mg 30 | 01/10/2024 | 4.55 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 80 mg 90 | 01/10/2024 | 16.31 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 24 mg-26 mg 180 | 01/10/2024 | 60.12 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 24 mg-26 mg 60 | 01/10/2024 | 20.04 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 49 mg-51 mg 180 | 01/10/2024 | 60.12 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 49 mg-51 mg 60 | 01/10/2024 | 20.04 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 97 mg-103 mg 180 | 01/10/2024 | 60.12 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 97 mg-103 mg 60 | 01/10/2024 | 20.04 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-160 mg-12.5 mg 30 | 01/10/2024 | 10.44 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-160 mg-25 mg 30 | 01/10/2024 | 10.44 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-320 mg-25 mg 30 | 01/10/2024 | 13.26 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 5 mg-160 mg-12.5 mg 30 | 01/10/2024 | 9.21 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 5 mg-160 mg-25 mg 30 | 01/10/2024 | 9.21 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 10 mg-160 mg 30 | 01/10/2024 | 10.44 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 10 mg-320 mg 30 | 01/10/2024 | 13.26 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 5 mg-160 mg 30 | 01/10/2024 | 9.21 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 5 mg-320 mg 30 | 01/10/2024 | 11.68 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 125 mg 30 | 01/10/2024 | 43.86 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 250 mg 30 | 01/10/2024 | 87.71 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 500 mg 30 | 01/10/2024 | 175.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXTAVIA KIT 0.3 mg 15 | 01/10/2024 | 231.33 | ||||
Rx0000073 | Novartis | 04/26/2024 | GILENYA CAPSULE 0.5 mg 30 | 01/10/2024 | 208.46 | ||||
Rx0000073 | Novartis | 10/31/2024 | ILARIS VIAL (ML) 150 mg/mL 1 VIAL | 07/03/2024 | 1272.03 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 180 mg 30 | 01/10/2024 | 87.71 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 360 mg 30 | 01/10/2024 | 175.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 90 mg 30 | 01/10/2024 | 43.86 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 180 mg 30 | 01/10/2024 | 87.71 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 360 mg 30 | 01/10/2024 | 175.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 90 mg 30 | 01/10/2024 | 43.86 | ||||
Rx0000073 | Novartis | 04/26/2024 | KESIMPTA PEN PEN INJECTOR (ML) 20 mg/0.4 mL 0.4 | 01/10/2024 | 571.49 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 200 mg/day (200 mg x 1)-2.5 mg 49 | 01/10/2024 | 524.01 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 400 mg/day (200 mg x 2)-2.5 mg 70 | 01/10/2024 | 1048.02 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 600 mg/day (200 mg x 3)-2.5 mg 91 | 01/10/2024 | 1310.03 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 200 mg/day (200 mg x 1) 21 | 01/10/2024 | 524.01 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 400 mg/day (200 mg x 2) 42 | 01/10/2024 | 1048.02 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 600 mg/day (200 mg x 3) 63 | 01/10/2024 | 1310.03 | ||||
Rx0000073 | Novartis | 07/31/2024 | KYMRIAH PLASTIC BAG, INJECTION (EA) 0.2 x 10exp6 to 2.5 x 10exp8 cell 1 | 04/01/2024 | 38067.93 | ||||
Rx0000073 | Novartis | 07/31/2024 | KYMRIAH PLASTIC BAG, INJECTION (EA) 0.6 x 10exp8 to 6 x 10exp8 cell 1 | 04/01/2024 | 29893.34 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET 0.25 mg 28 | 01/10/2024 | 86.18 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET 2 mg 30 | 01/10/2024 | 369.36 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET, DOSE PACK 0.25 mg (12 tabs) 12 | 01/10/2024 | 36.94 | ||||
Rx0000073 | Novartis | 04/26/2024 | MEKINIST TABLET 0.5 mg 30 | 01/10/2024 | 344.22 | ||||
Rx0000073 | Novartis | 04/26/2024 | MEKINIST TABLET 2 mg 30 | 01/10/2024 | 1171.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | MYFORTIC TABLET, DELAYED RELEASE (ENTERIC COATED) 180 mg 120 | 01/10/2024 | 23.72 | ||||
Rx0000073 | Novartis | 04/26/2024 | MYFORTIC TABLET, DELAYED RELEASE (ENTERIC COATED) 360 mg 120 | 01/10/2024 | 47.44 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL CAPSULE 100 mg 30 | 01/10/2024 | 9.35 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL CAPSULE 25 mg 30 | 01/10/2024 | 2.34 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL SOLUTION, ORAL 100 mg/mL 50 | 01/10/2024 | 16.99 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 200 mg/day (200 mg x 1) 28 | 01/10/2024 | 1632.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 250 mg/day (200 mg x 1 and 50 mg x 1) 56 | 01/10/2024 | 1632.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 300 mg/day (150 mg x 2) 56 | 01/10/2024 | 1632.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA POWDER IN PACKET (EA) 12.5 mg 30 | 01/10/2024 | 536.79 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA POWDER IN PACKET (EA) 25 mg 30 | 01/10/2024 | 536.82 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 12.5 mg 30 | 01/10/2024 | 536.79 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 25 mg 30 | 01/10/2024 | 536.79 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 50 mg 14 | 01/10/2024 | 453.33 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 50 mg 30 | 01/10/2024 | 971.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 75 mg 30 | 01/10/2024 | 1457.13 | ||||
Rx0000073 | Novartis | 04/26/2024 | RYDAPT CAPSULE 25 mg 112 | 01/10/2024 | 646.84 | ||||
Rx0000073 | Novartis | 04/26/2024 | RYDAPT CAPSULE 25 mg 56 | 01/10/2024 | 323.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | SCEMBLIX TABLET 20 mg 60 | 01/10/2024 | 1608.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | SCEMBLIX TABLET 40 mg 60 | 01/10/2024 | 1608.42 | ||||
Rx0000073 | Novartis | 04/26/2024 | TABRECTA TABLET 150 mg 56 | 01/10/2024 | 593.37 | ||||
Rx0000073 | Novartis | 04/26/2024 | TABRECTA TABLET 200 mg 56 | 01/10/2024 | 593.37 | ||||
Rx0000073 | Novartis | 04/26/2024 | TAFINLAR CAPSULE 50 mg 120 | 01/10/2024 | 837.29 | ||||
Rx0000073 | Novartis | 04/26/2024 | TAFINLAR CAPSULE 75 mg 120 | 01/10/2024 | 1079.06 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 150 mg 28 | 01/10/2024 | 1484.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 200 mg 28 | 01/10/2024 | 1484.56 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 50 mg 120 | 01/10/2024 | 1590.59 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL SUSPENSION, ORAL (FINAL DOSE FORM) 100 mg/5 mL 450 | 01/10/2024 | 5.65 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL TABLET 200 mg 100 | 01/10/2024 | 8.77 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 100 mg 100 | 01/10/2024 | 4.70 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 200 mg 100 | 01/10/2024 | 9.37 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 400 mg 100 | 01/10/2024 | 18.73 | ||||
Rx0000073 | Novartis | 04/26/2024 | TOBRADEX OINTMENT (GRAM) 0.3 %-0.1 % 3.5 | 01/10/2024 | 7.90 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL SUSPENSION, ORAL (FINAL DOSE FORM) 300 mg/5 mL (60 mg/mL) 250 | 01/10/2024 | 13.92 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 150 mg 100 | 01/10/2024 | 16.54 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 300 mg 100 | 01/10/2024 | 30.21 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 600 mg 100 | 01/10/2024 | 55.53 | ||||
Rx0000073 | Novartis | 04/26/2024 | TYKERB TABLET 250 mg 150 | 01/10/2024 | 289.18 | ||||
Rx0000073 | Novartis | 04/26/2024 | ZYKADIA TABLET 150 mg 84 | 01/10/2024 | 365.30 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 10 gm/100 mL single use vial | 05/01/2024 | 161.60 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 2.5 gm/ 25 mL single use vial | 05/01/2024 | 40.40 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 20 gm/200 mL single use vial | 05/01/2024 | 323.20 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 30 gm/300 mL single use vial | 05/01/2024 | 484.80 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 5 gm/50 mL single use vial | 05/01/2024 | 80.80 | ||||
Rx0000375 | Organon | 07/18/2024 | Pregnyl Intramuscular Solution Reconstituted 10000 Unit Package of 1 Vial | 06/24/2024 | 8.33 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Asimtufii 720mg Kit | 01/15/2024 | 150.92 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Asimtufii 960mg Kit | 01/15/2024 | 201.22 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 300mg Dual Chamber Syringe | 01/15/2024 | 75.46 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 300mg Kit | 01/15/2024 | 75.46 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 400mg Dual Chamber Syringe | 01/15/2024 | 100.61 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 400mg Kit | 01/15/2024 | 100.61 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 15mg tablets, 30 count bottle | 01/15/2024 | 480.45 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 15mg/15mg tablets, 4x weekly blister cards | 01/15/2024 | 896.84 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 30mg tablets, 30 count bottle | 01/15/2024 | 480.45 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 30mg/15mg tablets, 4x weekly blister cards | 01/15/2024 | 896.84 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 45mg/15mg tablets, 4x weekly blister cards | 01/15/2024 | 896.84 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 60mg/30mg tablets, 4x weekly blister cards | 01/15/2024 | 896.84 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 90mg/30mg tablets, 4x weekly blister cards | 01/15/2024 | 896.84 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Nuedexta 20mg/10mg CP, 60 count bottle | 01/15/2024 | 56.15 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 0.25mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 0.5mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 1mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 2mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 3mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 4mg tablets, 30 count bottle | 01/15/2024 | 52.50 | ||||
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 10 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 10 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 12.5 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 12.5 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 15 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 15 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 17.5 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 17.5 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 20 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 20 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 22.5 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 22.5 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 25 MG/0.4ML 1 Syringe | 162.45 | 162.45 | 137.00 | 04/01/2024 | 9.01 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 25 MG/0.4ML 4 Syringe | 649.78 | 649.78 | 548.00 | 04/01/2024 | 36.04 | |
Rx0000484 | Pacira Pharmaceuticals, Inc. | 04/18/2024 | EXPAREL 13.3mg/mL Injection Suspension Liposomal 10 vials in 1 carton | 01/01/2024 | 128.85 | ||||
Rx0000484 | Pacira Pharmaceuticals, Inc. | 04/18/2024 | EXPAREL 13.3mg/mL Injection Suspension Liposomal 4 vials in 1 carton | 01/01/2024 | 51.54 | ||||
Rx0000053 | Paratek Pharmaceuticals, Inc. | 10/17/2024 | Nuzyra 100mg/5mL Intravenous Injection; Powder; Lyophilized 10 Carton | 07/01/2024 | 131.11 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Acetylcysteine Solution Rx, 100 mg/mL (10 %), VIAL (ML), 30 | 01/01/2024 | 4.59 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Acetylcysteine Solution Rx, 200 mg/mL (20 %), VIAL (ML), 30 | 01/01/2024 | 4.51 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ADD-Vantage, ADDapter Connector, 1 | 01/01/2024 | 4.04 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Aminophylline Injection Rx, 250 mg/10 mL, VIAL (ML), 10 | 01/01/2024 | 35.77 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Antivenin (micrurus fulvius equine origin), 10mL, VIAL (ML), 1 | 01/01/2024 | 345.70 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATGAM (lymphocyte immune globulin,antithymocyte (equine)), 50 mg/mL, Ampul(ML), 5 | 01/01/2024 | 1732.05 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.05 mg/mL, SYRINGE (ML), 1 | 01/01/2024 | 20.38 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.1 mg/mL, SYRINGE (ML), 1 | 01/01/2024 | 15.26 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.1 mg/mL, SYRINGE (ML), 1 | 01/01/2024 | 13.32 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 1000 unit, VIAL (EA), 1 | 01/01/2024 | 86.13 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 2000 unit, VIAL (EA), 1 | 01/01/2024 | 172.27 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 250 unit, VIAL (EA), 1 | 01/01/2024 | 21.54 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 3000 unit, VIAL (EA), 1 | 01/01/2024 | 258.40 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 500 unit, VIAL (EA), 1 | 01/01/2024 | 43.07 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (600,000/600,000), SYRINGE (ML), 1 | 01/01/2024 | 200.92 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (600,000/600,000), SYRINGE (ML), 1 | 01/01/2024 | 200.92 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (900,000/300,000), SYRINGE (ML), 1 | 01/01/2024 | 200.92 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 1.2 million unit/2 mL, SYRINGE (ML), 1 | 01/01/2024 | 252.06 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 2.4 million unit/4 mL, SYRINGE (ML), 1 | 01/01/2024 | 516.51 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 600,000 unit/mL, SYRINGE (ML), 1 | 01/01/2024 | 145.53 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 100 mg, TABLET, 1 | 01/01/2024 | 584.48 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 400 mg, TABLET, 1 | 01/01/2024 | 584.48 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 500 mg, TABLET, 1 | 01/01/2024 | 584.48 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BRAFTOVI (encorafenib), 75 mg, CAPSULE, 120 | 11499.00 | 10977.00 | 10977.00 | 01/01/2024 | 900.45 | |
Rx0000006 | Pfizer | 04/29/2024 | BRAFTOVI (encorafenib), 75 mg, CAPSULE, 180 | 11499.00 | 10977.00 | 10977.00 | 01/01/2024 | 900.45 | |
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 1 mg/mL (1 mg/mL) Single Dose Glass Fliptop Vial, 10 | 01/01/2024 | 6.13 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 2 mg/mL (2 mg/mL) Single Dose Glass Fliptop Vial, 10 | 01/01/2024 | 7.50 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 2 mg/mL (4 mg/2 mL) Single Dose Glass Fliptop Vial, 10 | 01/01/2024 | 10.56 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Cerebyx® (fosphenytoin sodium) Injection Rx, 100 mg PE/2 mL Vial, 25 | 01/01/2024 | 48.13 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Cerebyx® (fosphenytoin sodium) Injection Rx, 500 mg PE/10 mL Vial, 10 | 01/01/2024 | 57.76 | ||||
Rx0000006 | Pfizer | 04/29/2024 | COPPER CHLORIDE (cupric chloride), 0.4 mg/mL, VIAL (ML), 25 | 01/01/2024 | 65.52 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Demerol (meperidine hydrochloride) Injection - Controlled Substance - SCHEDULE II Rx, 50 mg/mL (1,500 mg/30 mL) Multiple Dose Glass Fliptop Vial, 1 | 01/01/2024 | 10.32 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DEPO-ESTRADIOL (estradiol cypionate), 5 mg/mL, VIAL (ML), 1 | 01/01/2024 | 16.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Dextran (dextran) Injection Rx, 500 mL (10% LMD in 0.9% Sodium Chloride), Intravenous solution, 12 | 01/01/2024 | 43.84 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Dextran (dextran) Injection Rx, 500 mL (10% LMD in 5% Dextrose), Intravenous solution, 12 | 01/01/2024 | 42.59 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Diazepam Injection - Controlled Substance - SCHEDULE IV Rx, 5 mg/mL, VIAL (ML), 10 | 01/01/2024 | 22.72 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DOPAMINE HCL (dopamine HCl), 200 mg/5 mL (40 mg/mL), VIAL (ML), 25 | 01/01/2024 | 6.24 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DOPAMINE HCL (dopamine HCl), 400 mg/10 mL (40 mg/mL), VIAL (ML), 1 | 01/01/2024 | 5.03 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Epinephrine Injection Rx, 1mg/10mL (0.1 mg/mL) ABBOJECT Single-dose syringe, 10 | 01/01/2024 | 7.67 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Gemcitabine Injection (Lyophilized) Rx, 200 mg, VIAL (EA), 1 | 01/01/2024 | 0.96 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Gentamicin Sulfate Injection Rx, 40 mg/mL (80 mg/2 mL) Single Dose Glass Fliptop Vial, 25 | 01/01/2024 | 13.75 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 100 Units/mL (25,000 Units/250 mL) Flexible Container, 24 | 01/01/2024 | 31.04 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 12500 unit/250 mL, INTRAVENOUS SOLUTION, 250 | 01/01/2024 | 33.56 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 25000 unit/250 mL (100 unit/mL), INTRAVENOUS SOLUTION, 250 | 01/01/2024 | 38.80 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 25000 unit/500 mL (50 unit/mL), INTRAVENOUS SOLUTION, 500 | 01/01/2024 | 19.49 | ||||
Rx0000006 | Pfizer | 04/29/2024 | HEXTEND LACTATED ELECTROLYTE (hetastarch/electrolyte solution,lactated), 500mL, Vial, 12 | 01/01/2024 | 104.58 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 100 mg, CAPSULE, 1 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 100 mg, TABLET, 21 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 125 mg, CAPSULE, 1 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 125 mg, TABLET, 21 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 75 mg, CAPSULE, 1 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 75 mg, TABLET, 21 | 01/01/2024 | 904.66 | ||||
Rx0000006 | Pfizer | 04/29/2024 | INLYTA (axitinib), 1 mg, TABLET, 1 | 01/01/2024 | 598.42 | ||||
Rx0000006 | Pfizer | 04/29/2024 | INLYTA (axitinib), 5 mg, TABLET, 1 | 01/01/2024 | 598.42 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LIDOCAINE HCL (lidocaine HCl/PF), 50 mg/5 mL (1 %), SYRINGE (ML), 1 | 01/01/2024 | 10.24 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LIDOCAINE HCL (lidocaine HCl/PF), 50 mg/5 mL (1 %), SYRINGE (ML), 1 | 01/01/2024 | 14.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LORBRENA (lorlatinib), 100 mg, TABLET, 1 | 01/01/2024 | 1209.03 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LORBRENA (lorlatinib), 25 mg, TABLET, 1 | 01/01/2024 | 403.01 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MAGNESIUM SULFATE (magnesium sulfate), 4 mEq/mL (50 %), SYRINGE (ML), 1 | 01/01/2024 | 27.83 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MANGANESE CHLORIDE (manganese chloride), 0.1 mg/mL, VIAL (ML), 25 | 01/01/2024 | 77.02 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Mannitol Injection Rx, 25% (12.5 g/50 mL), Vial, 25 | 01/01/2024 | 3.50 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 2.5 mg/mL (25 mg/10 mL), Vial, 10 | 01/01/2024 | 4.21 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 2.5 mg/mL (75 mg/30 mL), Vial, 10 | 01/01/2024 | 10.55 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 5 mg/mL (50 mg/10 mL), Vial, 10 | 01/01/2024 | 4.56 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride and epinephrine) Injection for NovaPlus, 2.5 mg/mL (0.25 %)-1:200000, VIAL (ML), 10 | 01/01/2024 | 4.21 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride and epinephrine) Injection for NovaPlus, 2.5 mg/mL (0.25 %)-1:200000, VIAL (ML), 30 | 01/01/2024 | 10.55 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride) Injection Rx, 2.5 mg/mL, VIAL (ML), 10 | 01/01/2024 | 3.67 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MEKTOVI (binimetinib), 15 mg, TABLET, 180 | 11499.00 | 10977.00 | 10977.00 | 01/01/2024 | 883.46 | |
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection for NovaPlus® Rx, 10 mg/mL, AMPUL (ML), 1 | 01/01/2024 | 4.02 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection for NovaPlus® Rx, 10 mg/mL, AMPUL (ML), 1 | 01/01/2024 | 4.02 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 10 mg/mL, AMPUL (ML), 1 | 01/01/2024 | 4.05 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 10 mg/mL, AMPUL (ML), 1 | 01/01/2024 | 4.05 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 20 mg/mL, AMPUL (ML), 1 | 01/01/2024 | 6.97 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nipent (pentostatin) Injection Rx, 10 mg, VIAL (EA), 1 | 01/01/2024 | 243.91 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 300 mg, TABLET FOR SUSPENSION, 60 | 01/01/2024 | 685.71 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 300 mg, TABLET FOR SUSPENSION, 90 | 01/01/2024 | 685.71 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 500 mg, TABLET, 90 | 01/01/2024 | 685.71 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 10 g/100 mL Vial, 1 | 01/01/2024 | 81.80 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 2.5 g/25 mL Vial, 1 | 01/01/2024 | 20.45 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 20 g/200 mL Vial, 1 | 01/01/2024 | 163.60 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 30 g/300 mL Vial, 1 | 01/01/2024 | 245.84 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 5 g/50 mL Vial, 1 | 01/01/2024 | 40.90 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium), 13.5 gram, VIAL (EA), 1 | 01/01/2024 | 5.97 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PLEGISOL (cardioplegic solution), 1000mL, PLASTIC BAG, PERFUSION (ML), 12 | 01/01/2024 | 84.57 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Potassium Chloride Concentrate Injection Rx, 2 mEq/mL, VIAL (ML), 10 | 01/01/2024 | 4.54 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Potassium Chloride Concentrate Injection Rx, 2 mEq/mL, VIAL (ML), 5 | 01/01/2024 | 5.91 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Prempro® (conjugated estrogens/medroxy progesterone acetate) Tablets Rx, 0.3 mg-1.5 mg, TABLET, 28 | 01/01/2024 | 7.04 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PREPIDIL (dinoprostone), 0.5 mg/3 gram, GEL WITH PREFILLED APPLICATOR (GRAM), 1 | 01/01/2024 | 36.10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 4.2% (5mEq/10mL) per glass Abboject® syringe, 10 | 01/01/2024 | 16.62 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 7.5% (44/6 mEq/50mL) per glass Abboject® syringe, 10 | 01/01/2024 | 21.53 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 8.4% (10mEq/10mL) per glass vial Abboject® syringe, 10 | 01/01/2024 | 21.46 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 8.4% (50mEq/50mL) per glass Abbotject® syringe, 10 | 01/01/2024 | 15.85 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate) 500 mg/4 mL, VIAL (EA), 1 | 01/01/2024 | 3.60 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg, VIAL (EA), 1 | 01/01/2024 | 0.72 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg/2 mL, VIAL (EA), 1 | 01/01/2024 | 24.30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg/2 mL, VIAL EA, 1 | 01/01/2024 | 0.97 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 250 mg/2 mL VIAL (EA), 1 | 01/01/2024 | 1.80 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 250 mg/2 mL, VIAL EA 1 | 01/01/2024 | 44.94 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF(hydrocortisone sodium succinate), 1000 mg/8 mL, VIAL EA 1 | 01/01/2024 | 7.19 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Solu-Medrol® (methylprednisolone sodium succinate) Sterile Powder for Injection Rx, 2 gram, VIAL (EA), 1 | 01/01/2024 | 9.43 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 10 mg, VIAL (EA), 1 | 01/01/2024 | 10.30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 15 mg, VIAL (EA), 1 | 01/01/2024 | 15.45 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 20 mg, VIAL (EA), 1 | 01/01/2024 | 20.60 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 25 mg, VIAL (EA), 1 | 01/01/2024 | 25.75 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 30 mg, VIAL (EA), 1 | 01/01/2024 | 30.90 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Talzenna® (talazoparib) Rx, 0.25 mg, CAPSULE, 30 | 01/01/2024 | 175.14 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Talzenna® (talazoparib) Rx, 1 mg, CAPSULE, 30 | 01/01/2024 | 525.42 | ||||
Rx0000006 | Pfizer | 04/29/2024 | THAM (tromethamine), 36 mg/mL (0.3 M), INTRAVENOUS SOLUTION, 6 | 01/01/2024 | 194.67 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TPN ELECTROLYTES (multiple electrolyte additive) Solution Rx, 20 mL, VIAL (ML), 25 | 01/01/2024 | 21.32 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TRUMENBA (Neisseria meningitidis group B, lipidated fHBP recombinant), 120 mcg / 0.5 mL, SYRINGE (ML), 1 | 01/01/2024 | 105.58 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TRUMENBA (Neisseria meningitidis group B, lipidated fHBP recombinant), 120 mcg/0.5 mL, SYRINGE (ML), 1 | 01/01/2024 | 52.79 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Verapamil Hydrochloride Injection Rx, 2.5 mg/mL (10 mg/4 mL) Ansyr Plastic Syringe, 10 | 01/01/2024 | 73.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL (ML) 1 | 01/01/2024 | 1.41 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL (ML) 1 | 01/01/2024 | 1.41 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL ML, 1 | 01/01/2024 | 1.61 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL ML, 1 | 01/01/2024 | 1.61 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL VIAL (ML), 1 | 01/01/2024 | 1.42 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL VIAL (ML), 1 | 01/01/2024 | 1.42 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL, VIAL (ML), 1 | 01/01/2024 | 1.55 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL, VIAL (ML), 1 | 01/01/2024 | 1.55 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 15 mg, TABLET, 1 | 01/01/2024 | 466.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 30 mg, TABLET, 1 | 01/01/2024 | 466.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 45 mg, TABLET, 1 | 01/01/2024 | 466.87 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Vyndamax (tafamidis) Capsule Rx, 61 mg, CAPSULE, 30 | 01/01/2024 | 1460.99 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Vyndaqel® (tafamidis meglumine) Capsules Rx, 20 mg, CAPSULE, 120 | 01/01/2024 | 1460.99 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XALKORI (crizotinib), 200 mg, CAPSULE, 1 | 01/01/2024 | 1269.48 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XALKORI (crizotinib), 250 mg, CAPSULE, 1 | 01/01/2024 | 1269.48 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ (tofacitinib citrate), 10 mg, TABLET, 1 | 01/01/2024 | 270.17 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ (tofacitinib citrate), 5 mg, TABLET, 1 | 01/01/2024 | 270.17 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ XR (tofacitinib citrate), 11 mg, TABLET, EXTENDED RELEASE 24 HR, 1 | 01/01/2024 | 270.17 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ XR (tofacitinib citrate), 22 mg, TABLET, EXTENDED RELEASE 24 HR, 30 | 01/01/2024 | 270.17 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Xeljanz® (tofacitinib ) Oral Solution Rx, 1 mg/mL, SOLUTION ORAL, 240 | 01/01/2024 | 216.14 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | (DIPHENHYDRAMINE HYDROCHLORIDE) DIPHENHYDRAMINE HYDROCHLORIDE 12.5mg/5mL Oral Elixir, 5mL Cup [Qty: 1] | 12/01/2024 | 0.38 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 10mL Cup [Qty: 1] | 12/01/2024 | 0.37 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 10mL Cup [Qty: 100] | 12/01/2024 | 37.22 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 5mL Cup [Qty: 100] | 12/01/2024 | 37.53 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE) 325mg/15mL;7.5mg/15mL Oral Solution, 5mL Cup [Qty: 1] | 12/01/2024 | 0.83 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE) 325mg/15mL;7.5mg/15mL Oral Solution, 5mL Cup [Qty: 40] | 12/01/2024 | 33.44 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 04/02/2024 | Lactulose Oral Solution 10 GM/15ML - 473mL Bottle [Qty: 1] | 03/15/2024 | 6.30 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 04/02/2024 | Lactulose Oral Solution 10 GM/15ML. - 946mL Bottle [Qty: 1] | 03/15/2024 | 13.90 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 15mL Cup [Qty: 1] | 12/01/2024 | 0.42 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 15mL Cup [Qty: 100] | 12/01/2024 | 42.11 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 30mL Cup [Qty: 1] | 12/01/2024 | 0.45 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 30mL Cup [Qty: 100] | 12/01/2024 | 45.69 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE; TRIMETHOPRIM) | 12/01/2024 | 1.48 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE; TRIMETHOPRIM) 200-40mg/5mL Oral Suspension, 20mL Cup [Qty: 40] | 12/01/2024 | 59.06 | ||||
Rx0000319 | Pharmacosmos Therapeutics | 03/31/2024 | Monoferric (ferric derisomaltose) Injection 1000mg/10mL 1 unit vial | 01/01/2024 | 240.50 | ||||
Rx0000410 | PharmaEssentia USA Corporation | 05/13/2024 | Besremi Subcutaneous Solution Prefilled Syringe 500 MCG/ML | 04/01/2024 | 161.00 | ||||
Rx0000410 | PharmaEssentia USA Corporation | 03/31/2024 | Besremi Subcutaneous Solution Prefilled Syringe 500 MCG/ML, 1 1ML syringe per package | 01/16/2024 | 315.00 | ||||
Rx0000469 | Pharming Healthcare Inc | 04/12/2024 | Ruconest 2100 U; Injection; Powder for Solution; 1 Carton | 01/01/2024 | 355.00 | ||||
Rx0000469 | Pharming Healthcare Inc | 04/12/2024 | Ruconest C1 Esterase Inhibitor (Recombinant) 2100 UNIT Solution Reconstituted 1 EA UD | 01/01/2024 | 355.00 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 1000mg, 6 x 10 | 06/06/2024 | 45.07 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 250mg, 6 x 10 | 06/06/2024 | 45.07 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 500mg, 6 x 10 | 06/06/2024 | 45.07 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 750mg, 6 x 10 | 06/06/2024 | 45.07 | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 15mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | 02/05/2024 | 156.87 | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 30mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | 02/05/2024 | 211.42 | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 5mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | 02/05/2024 | 127.20 | ||||
Rx0000220 | Puma Biotechnology, Inc. | 03/31/2024 | Nerlynx Oral Tablet 40 mg, 133 tablet package | 01/16/2024 | 1070.00 | ||||
Rx0000220 | Puma Biotechnology, Inc. | 03/31/2024 | Nerlynx Oral Tablet 40 mg, 180 tablet package | 01/16/2024 | 1450.00 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 10MG TABLETS 100S | 01/01/2024 | 44.03 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 10MG TABLETS HUD 20S | 01/01/2024 | 9.04 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 15MG TABLETS 100S | 01/01/2024 | 64.82 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 15MG TABLETS HUD 20S | 01/01/2024 | 13.30 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 20MG TABLETS 100S | 01/01/2024 | 82.11 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 20MG TABLETS HUD 20S | 01/01/2024 | 16.84 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 30MG TABLETS 100S | 01/01/2024 | 114.19 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 30MG TABLETS HUD 20S | 01/01/2024 | 23.43 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 40MG TABLETS 100S | 01/01/2024 | 140.62 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 40MG TABLETS HUD 20S | 01/01/2024 | 28.83 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 60MG TABLETS 100S | 01/01/2024 | 199.10 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 60MG TABLETS HUD 20S | 01/01/2024 | 40.85 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 80MG TABLETS 100S | 01/01/2024 | 245.38 | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 80MG TABLETS HUD 20S | 01/01/2024 | 50.34 | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Davimet with Fluoride 0.75mg, chewable multivitamin, Grape flavor, 30 tablets, Vit A, Vit C, Vit D3, Vit. E, Thiamin, Riboflavin, Niacin, Vit. B6, Folate, Vit. B12, Fluoride | 04/08/2024 | 1129.00 | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Hydroxate Gel, gel, hydrocortisone 2%, 1oz | 04/04/2024 | 275.00 | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Hydroxym Cream, Anti-itch cream, hydrocortisone 2%, 1oz | 04/08/2024 | 275.00 | ||||
Rx0000356 | Radius Health, Inc. | 03/31/2024 | TYMLOS 80 MCG Pen | 01/01/2024 | 151.02 | ||||
Rx0000356 | Radius Health, Inc. | 03/31/2024 | TYMLOS 80 MCG Pen / Carton | 01/01/2024 | 151.02 | ||||
Rx0000363 | Recordati Rare Diseases, inc. | 12/13/2024 | Sylvant Intravenous Solution Reconstituted 100 MG 1 Vial | 10/01/2024 | 40.54 | ||||
Rx0000363 | Recordati Rare Diseases, inc. | 12/13/2024 | Sylvant Intravenous Solution Reconstituted 400 MG 1 Vial | 10/01/2024 | 162.15 | ||||
Rx0000166 | Redhill Biopharma, Inc. | 04/22/2024 | Talicia, Amoxicillin-Rifabutin-Omeprazole Cap DR 250-12.5-10 MG, 84 Each, Unit-of-Use, Bottle | 02/01/2024 | 22.96 | ||||
Rx0000166 | Redhill Biopharma, Inc. | 04/22/2024 | Talicia, Amoxicillin-Rifabutin-Omeprazole Cap DR 250-12.5-10 MG, 84 Each, Unit-of-Use, Bottle Qty 2 | 02/01/2024 | 45.93 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Dronabinol Capsules 2.5mg 60s | 06/28/2024 | 40.67 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Hydromorphone HCL 4mg Tablets 100s | 05/13/2024 | 22.02 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Hydromorphone HCL 8mg Tablets 100s | 05/13/2024 | 24.99 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 04/23/2024 | Morphine Sulfate ER 15mg Tablets 100s | 01/26/2024 | 25.41 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Oxycodone Hydrochloride 20mg Tablets 100s | 04/01/2024 | 19.93 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Oxycodone Hydrochloride 30mg Tablets 100s | 04/01/2024 | 20.87 | ||||
Rx0000239 | Rigel Pharmaceuticals, Inc. | 04/04/2024 | TAVALISSE TAB 100MG 60 TABS | 01/04/2024 | 820.00 | ||||
Rx0000239 | Rigel Pharmaceuticals, Inc. | 04/04/2024 | TAVALISSE Tab 150MG 60 TABS | 01/04/2024 | 820.00 | ||||
Rx0000158 | RISING PHARMA HOLDINGS, INC. | 04/05/2024 | METHIMAZOLE TAB 10 MG 100CT | 03/01/2024 | 38.90 | ||||
Rx0000158 | RISING PHARMA HOLDINGS, INC. | 04/05/2024 | METHIMAZOLE TAB 5 MG 100CT | 03/01/2024 | 22.90 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | COLAZAL® (balsalazide disodium) 750mg Capsules, 280ct BTL | 01/01/2024 | 51.54 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) 12mg/0.6mL, vial | 01/01/2024 | 6.46 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 12 mg/0.6mL, 7ct | 01/01/2024 | 45.23 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 12 mg/0.6mL, vial | 01/01/2024 | 6.46 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 8 mg/0.4mL, 7ct | 01/01/2024 | 45.23 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) Tablets 150mg, 90ct | 01/01/2024 | 58.07 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | Trulance® (plecanatide) 3mg Tablets, 30 | 411.78 | 388.47 | 353.48 | 01/01/2024 | 19.39 | |
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | XIFAXAN® (rifaximin) 550mg Tablets HUD 6 cards of 10, 60ct Card | 01/01/2024 | 107.44 | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | XIFAXAN® (rifaximin) 550mg Tablets, 60ct | 01/01/2024 | 107.44 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | CILOXAN OINTMENT 0.3% 3.5G 1EOIN US | 03/15/2024 | 24.49 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 0.25MG 10HGC US | 03/15/2024 | 109.34 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 1MG 10HGC US | 03/15/2024 | 437.34 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 4MG 1LYVI US | 03/15/2024 | 125.94 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LESCOL XL 80MG 30TAB US | 03/15/2024 | 36.90 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 10+20MG 100HGC BO US | 03/15/2024 | 133.06 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 10+40MG 100HGC BO US | 03/15/2024 | 146.61 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 5+10MG 100HGC BO US | 03/15/2024 | 108.45 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 5+20MG 100HGC BO US | 03/15/2024 | 114.53 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RECLAST 5MG/100ML 1LIVI US | 03/15/2024 | 117.92 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 10MG 100TAB BO US | 03/15/2024 | 10.70 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 20MG 100TAB BO US | 03/15/2024 | 15.38 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 5MG 100TAB BO US | 03/15/2024 | 7.50 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 10MG 100PRCH US | 03/15/2024 | 113.69 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 20MG 100PRCH US | 03/15/2024 | 113.69 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 30MG 100PRCH US | 03/15/2024 | 116.28 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 40MG 100PRCH US | 03/15/2024 | 119.51 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | TRAVATAN Z SOL .004% 2.5ML LDP US | 03/15/2024 | 22.16 | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | TRAVATAN Z SOL .004% 5ML LDP US | 03/15/2024 | 44.32 | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 100 mg/0.67 mL (0.67 mL/syringe) - 2 syringes | 01/03/2024 | 215.28 | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 200 mg/1.14 mL (1.14 mL/pen) - 2 pens | 01/03/2024 | 215.28 | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 200 mg/1.14 mL (1.14 mL/syringe) - 2 syringes | 01/03/2024 | 215.28 | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 300 mg/2 mL (2 mL/pen) - 2 pens | 01/03/2024 | 215.28 | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 300 mg/2 mL (2 mL/syringe) - 2 syringes | 01/03/2024 | 215.28 | ||||
Rx0000011 | Sanofi | 10/30/2024 | Jevtana® (cabazitaxel) Injection Concentrate) 60mg vial, 1.5ml carton | 07/01/2024 | 277.38 | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 150 mg/1.14 mL pen - carton of 2 pens | 01/03/2024 | 245.84 | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 150 mg/1.14 mL syringe - carton of 2 syringes | 01/03/2024 | 245.84 | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 200 mg/1.14 mL pen - carton of 2 pens | 01/03/2024 | 245.84 | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 200 mg/1.14 mL syringe - carton of 2 syringes | 01/03/2024 | 245.84 | ||||
Rx0000011 | Sanofi | 04/30/2024 | MenQuadfi® (Meningococcal tetanus conjugate vaccine)10 mcg/0.5 mL (0.5 mL dose/vial) - 5 vials | 01/01/2024 | 54.38 | ||||
Rx0000011 | Sanofi | 10/30/2024 | Typhim Vi® (Typhoid vaccine) 0.5 mL (1-dose) syringe | 07/01/2024 | 6.65 | ||||
Rx0000011 | Sanofi | 10/30/2024 | Typhim Vi® (Typhoid vaccine) 10 mL (0.5 mL dose) vial | 07/01/2024 | 91.90 | ||||
Rx0000011 | Sanofi | 04/30/2024 | Typhim Vi® (Typhoid vaccine)25 mcg/0.5 mL (0.5 ml dose/10 mL vial) - 1 vial | 01/01/2024 | 151.75 | ||||
Rx0000011 | Sanofi | 04/30/2024 | Typhim Vi® (Typhoid vaccine)25 mcg/0.5 mL (0.5 ml dose/syringe) - 1 syringe | 01/01/2024 | 10.98 | ||||
Rx0000011 | Sanofi | 10/30/2024 | YF-VAX® (Yellow fever vaccine) 0.5 mL (1-dose) vial | 07/01/2024 | 48.92 | ||||
Rx0000011 | Sanofi | 04/30/2024 | YF-VAX® (Yellow fever vaccine)10 exp4.74 unit/0.5 mL (0.5 mL dose/vial) - 5 vials | 01/01/2024 | 80.79 | ||||
Rx0000092 | Santarus, Inc. | 04/28/2024 | CYCLOSET® (bromocriptine mesytate tablets) 0.8 mg tablets, 200 ct | 01/01/2024 | 18.88 | ||||
Rx0000086 | Seagen, Inc. | 07/18/2024 | ADCETRIS, 50mg, single-dose vial, packaged singly | 06/27/2024 | 440.00 | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | PADCEV (enfortumab vedotin-ejfv) 20 mg lyophilized powder in a single-dose vial for reconstitution | 03/28/2024 | 55.00 | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | PADCEV (enfortumab vedotin-ejfv) 30 mg lyophilized powder in a single-dose vial for reconstitution | 03/28/2024 | 82.50 | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | TIVDAK (tisotumab vedotin-tftv) 40mg/vial, Lyophilized Powder in a single-dose vial for reconstitution | 03/28/2024 | 257.00 | ||||
Rx0000086 | Seagen, Inc. | 10/31/2024 | TIVDAK (tisotumab vedotin-tftv) 40mg/vial, Lyophilized Powder in a single-dose vial for reconstitution | 09/26/2024 | 267.00 | ||||
Rx0000028 | Servier Pharmaceuticals LLC | 04/24/2024 | Oncaspar Injection Solution 750 UNIT/ML, 5 ML, Unit-Dose, Vial | 01/03/2024 | 1216.11 | ||||
Rx0000028 | Servier Pharmaceuticals LLC | 04/24/2024 | Tibsovo Oral Tablet 250 MG, 60 Each, Bottle | 28380.00 | 27420.75 | 26115.00 | 01/03/2024 | 965.66 | |
Rx0000175 | Sobi Inc | 04/12/2024 | KINERET (anakinra) 100 MG/0.67 ML SYRINGE. 7 syringes in 1 carton (.67 ML in 1 syringe). | 01/01/2024 | 90.17 | ||||
Rx0000244 | Sprout Pharmaceuticals, Inc. | 09/09/2024 | ADDYI (FLIBANSERIN) 100mg Oral Tablet, 30ct Bottle - [Qty:1] | 09/15/2024 | 120.00 | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 200 MG | 01/01/2024 | 72.00 | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 400 MG | 01/01/2024 | 72.00 | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 800 MG | 01/01/2024 | 72.00 | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 60 Oral Tablets 600 MG | 01/01/2024 | 144.00 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 150 MG Package Size 100 Package Qty 1 | 01/01/2024 | 51.11 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 300 MG Package Size 100 Package Qty 1 | 01/01/2024 | 71.01 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 600 MG Package Size 100 Package Qty 1 | 01/01/2024 | 130.00 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 100 MG Package Size 30 Package Qty 1 | 01/01/2024 | 20.16 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 150 MG Package Size 30 Package Qty 1 | 01/01/2024 | 20.16 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 200 MG Package Size 30 Package Qty 1 | 01/01/2024 | 20.16 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 180 MG TABLET * 30 PACK | 01/04/2024 | 670.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 180 MG TABLET * 30 PACK | 07/01/2024 | 396.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 30 MG TABLET * 30 PACK | 01/04/2024 | 223.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 30 MG TABLET * 30 PACK | 07/01/2024 | 132.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 90 MG TABLET * 30 PACK | 01/04/2024 | 670.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 90 MG TABLET * 30 PACK | 07/01/2024 | 396.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 90 MG TABLET * 7 PACK | 01/04/2024 | 157.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 90 MG TABLET * 7 PACK | 07/01/2024 | 93.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG INITIATION PACK - 7 CT 90 MG TABLET and 23 CT 180 MG TABLET - PER PACK | 01/04/2024 | 670.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG INITIATION PACK - 7 CT 90 MG TABLET and 23 CT 180 MG TABLET - PER PACK | 07/01/2024 | 396.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/15/2024 | Entyvio Intravenous Solution Reconstituted 300 MG | 01/01/2024 | 490.56 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 10 MG TABLET * 30 PACK | 01/04/2024 | 705.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 10 MG TABLET * 30 PACK | 07/01/2024 | 938.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 15 MG TABLET * 30 PACK | 01/04/2024 | 705.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 15 MG TABLET * 30 PACK | 07/01/2024 | 938.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 30 MG TABLET * 30 PACK | 01/04/2024 | 705.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 30 MG TABLET * 30 PACK | 07/01/2024 | 938.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 45 MG TABLET * 30 PACK | 01/04/2024 | 705.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 45 MG TABLET * 30 PACK | 07/01/2024 | 938.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 2.3 MG CAPSULE * 3 PACK | 01/04/2024 | 734.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 2.3 MG CAPSULE * SINGLE PACK | 01/04/2024 | 245.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 3.0 MG CAPSULE * 3 PACK | 01/04/2024 | 734.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 4.0 MG CAPSULE * 3 PACK | 01/04/2024 | 734.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 4.0 MG CAPSULE * SINGLE PACK | 01/04/2024 | 245.00 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 3.0 MG CAPSULE * SINGLE PACK | 01/04/2024 | 245.00 | ||||
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Xermelo Oral Tablet 250 MG, 84 Each, Unit-of-Use, Box | 6559.00 | 5961.00 | 5164.00 | 01/01/2024 | 863.02 | |
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Zoladex Subcutaneous Implant 10.8 MG, 1 Each, Unit-of-Use, Box | 01/01/2024 | 239.04 | ||||
Rx0000232 | TerSera Therapeutics LLC | 10/30/2024 | Zoladex Subcutaneous Implant 10.8 MG, 1 Each, Unit-of-Use, Box | 07/01/2024 | 130.03 | ||||
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Zoladex Subcutaneous Implant 3.6 MG, 1 Each, Unit-Dose, Syringe | 01/01/2024 | 85.25 | ||||
Rx0000232 | TerSera Therapeutics LLC | 10/30/2024 | Zoladex Subcutaneous Implant 3.6 MG, 1 Each, Unit-Dose, Syringe | 07/01/2024 | 46.38 | ||||
Rx0000302 | Tetraphase Pharmaceuticals | 04/24/2024 | Xerava Intravenous Solution Reconstituted 50 MG, 1 Each, Unit-Dose, Vial Qty 12 | 01/02/2024 | 54.00 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 12 MG TABLET 60 | 01/01/2024 | 240.70 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 6 MG TABLET 60 | 01/01/2024 | 160.50 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 9 MG TABLET 60 | 01/01/2024 | 180.60 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AZILECT 0.5MG TABLET 30 | 01/01/2024 | 98.30 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AZILECT 1MG TABLET 30 | 01/01/2024 | 98.30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 10MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 12.5MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 15MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 20MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 30MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 5MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 7.5MG TABLET 100 | 01/01/2024 | 92.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADIPEX-P TABLETS 37.5 MG 100 | 01/01/2024 | 23.40 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADIPEX-P TABLETS 37.5 MG 30 | 01/01/2024 | 5.44 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | AMRIX 15 MG CAPSULE ER 60 | 01/01/2024 | 299.20 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | AMRIX 30 MG CAPSULE ER 60 | 01/01/2024 | 299.20 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 100 MCG TABLET 28 | 01/01/2024 | 189.20 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 200 MCG TABLET 28 | 01/01/2024 | 239.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 400 MCG TABLET 28 | 01/01/2024 | 346.90 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 600 MCG TABLET 28 | 01/01/2024 | 450.30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 800 MCG TABLET 28 | 01/01/2024 | 554.80 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FIORICET 50/300/40 MG CAPSULE 100 | 01/01/2024 | 66.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FIORICET 50/300/40/30 MG CAPSULE 100 | 01/01/2024 | 138.40 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | GALZIN 25 MG CAPSULE 250 | 01/01/2024 | 48.80 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | GALZIN 50 MG CAPSULE 250 | 01/01/2024 | 81.30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 150MG TABLET 30 | 01/01/2024 | 80.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 200MG TABLET 30 | 01/01/2024 | 80.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 250MG TABLET 30 | 01/01/2024 | 80.10 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 50MG TABLET 30 | 01/01/2024 | 26.60 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROGLYCEM 50MG/ML ORAL SUS 30ML | 01/01/2024 | 38.20 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROVIGIL 100MG TABLET 30 | 01/01/2024 | 112.00 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROVIGIL 200MG TABLET 30 | 01/01/2024 | 169.30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 10/17/2024 | SMX-TMP INJ 80MG-16MG/ML 10 X 10ML PRM | 07/11/2024 | 32.51 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 10/17/2024 | SMX-TMP INJ 80MG-16MG/ML 10 X 10ML PRM | 07/11/2024 | 32.51 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | TRISENOX VIAL 2 MG/ML 6 ML | 01/01/2024 | 1002.40 | ||||
Rx0000218 | Teva Respiratory, LLC | 04/24/2024 | QNASL PEDS Nasal Aerosol Solution 40 MCG/ACT 6.8GM | 01/01/2024 | 8.87 | ||||
Rx0000218 | Teva Respiratory, LLC | 04/24/2024 | QNASL PLV Nasal Aerosol Solution 80 MCG/ACT | 01/01/2024 | 8.87 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 10 MG TABLET 30 | 01/01/2024 | 108.70 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 15 MG TABLET 30 | 01/01/2024 | 163.00 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 5 MG TABLET 30 | 01/01/2024 | 54.40 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 7.5 MG TABLET 30 | 01/01/2024 | 81.50 | ||||
Rx0000134 | Therakos, Inc. | 04/30/2024 | UVADEX (Methoxsalen) STERILE SOLUTION, 20 mcg/ML, 12 - 10ml vials per carton | 01/01/2024 | 284.00 | ||||
Rx0000395 | Travere Therapeutics, Inc. | 10/25/2024 | Filspari Oral Tablet 200 MG 30 tablets 1 bottle | 09/13/2024 | 1057.53 | ||||
Rx0000395 | Travere Therapeutics, Inc. | 10/25/2024 | Filspari Oral Tablet 400 MG 30 tablets 1 bottle | 09/13/2024 | 1057.53 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 100MG 60 TABLETS | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 100MG UNIT DOSE CARTON OF 100 TABLETS | 01/01/2024 | 103.14 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 10MG 60 TABLETS | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 10MG ORAL SOLUTION-300ML | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 25MG 60 TABLETS | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 25MG UNIT DOSE CARTON OF 100 TABLETS | 01/01/2024 | 103.14 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 50MG 60 TABLETS | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 50MG UNIT DOSE CARTON OF 100 TABLETS | 01/01/2024 | 103.14 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 75MG 60 TABLETS | 01/01/2024 | 61.88 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT IV INJECTION FOR INTRAVENOUS USE 50mg/5mL | 01/01/2024 | 26.52 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA LYOPHOLIZED POWDER FOR INJECTION, 2 X 200 MG VIALS | 01/01/2024 | 318.63 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA PRE-FILLED SYRINGE KIT, 2 X 200 MG/ML PRE-FILLED SYRINGES | 01/01/2024 | 318.63 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA PRE-FILLED SYRINGE STARTER KIT, 6 X 200 MG/ML PRE-FILLED SYRINGES | 01/01/2024 | 955.90 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | FINTEPLA 2.2MG/ML, 30ML | 1399.50 | 1278.00 | 1278.00 | 01/01/2024 | 69.34 | |
Rx0000090 | UCB, Inc | 04/30/2024 | FINTEPLA 2.2MG/ML, 360ML | 16794.00 | 15336.00 | 15336.00 | 01/01/2024 | 832.03 | |
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 1000MG-60 TABLETS | 01/01/2024 | 51.02 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 250MG-120 TABLETS | 01/01/2024 | 41.74 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 500 MG-120 TABLETS | 01/01/2024 | 51.02 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 750MG-120 TABLETS | 01/01/2024 | 69.12 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA IV-1ML INJECTION FOR INTRAVENOUS USE 500mg5mL 10 VIALS | 01/01/2024 | 28.66 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA ORAL SOLUTION-100MG-473ML | 01/01/2024 | 38.78 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA XR (LEVETIRACETAM) 500MG-60 TABLETS | 01/01/2024 | 23.12 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA XR 750MG (LEVETIRACETAM)-60 TABLETS | 01/01/2024 | 34.72 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NAYZILAM 5 MG NASAL SPRAY-0.2ML | 01/01/2024 | 28.02 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 1MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 2MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 3MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 4MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 6MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 8MG/24HR-30 TRANSDERMAL SYSTEM | 01/01/2024 | 36.30 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 100MG UD-60 TABLETS | 01/01/2024 | 52.34 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 100MG-60 TABLETS | 01/01/2024 | 47.57 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 150MG UD-60 TABLETS | 01/01/2024 | 55.43 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 150MG-60 TABLETS | 01/01/2024 | 50.38 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 200MG UD-60 TABLETS | 01/01/2024 | 55.44 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 200MG-60 TABLETS | 01/01/2024 | 50.40 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 50MG UD-60 TABLETS | 01/01/2024 | 33.48 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 50MG-60 TABLETS | 01/01/2024 | 30.43 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT INJECTION FOR INTRAVENOUS USE 200MG/20ML 10 VIALS | 01/01/2024 | 41.63 | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT ORAL SOLUTION 10MG-200ML | 01/01/2024 | 19.68 | ||||
Rx0000262 | Ultragenyx Pharmaceuticals Inc. | 04/03/2024 | Dojolvi .96 g/mL Oral Liquid 1 Carton | 01/05/2024 | 169.00 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .125 MG Oral Tablet 10 Pack | 01/01/2024 | 3.24 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .125 MG Oral Tablet 100 Pack | 01/01/2024 | 32.43 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .25 MG Oral Tablet 10 Pack | 01/01/2024 | 6.48 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .25 MG Oral Tablet 100 Pack | 01/01/2024 | 64.87 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 1 MG Oral Tablet 10 Pack | 01/01/2024 | 25.94 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 1 MG Oral Tablet 100 Pack | 01/01/2024 | 259.48 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 2.5 MG Oral Tablet 10 Pack | 01/01/2024 | 64.87 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 2.5 MG Oral Tablet 100 Pack | 01/01/2024 | 648.71 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 5 MG Oral Tablet 100 Pack | 01/01/2024 | 1297.43 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 5 MG Pack Oral Tablet 10 Pack | 01/01/2024 | 129.74 | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | Unituxin Intravenous Solution 17.5 MG/5ML 1 Vial in 1 Carton | 01/01/2024 | 1561.25 | ||||
Rx0000443 | USWM, LLC | 04/10/2024 | LUCEMYRA .18mg 36 Tablet | 01/15/2024 | 40.92 | ||||
Rx0000443 | USWM, LLC | 04/10/2024 | LUCEMYRA .18mg 96 Tablet | 01/15/2024 | 109.12 | ||||
Rx0000450 | Vericel Corporation | 10/23/2024 | MACI; (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) 1 BAG in 1 BOX (69866-1030-5) > 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-4) > 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-3) | 07/01/2024 | 4494.00 | ||||
Rx0000450 | Vericel Corporation | 10/23/2024 | MACI; (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) 2 BAG in 1 BOX > 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-7) > 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-6) | 07/01/2024 | 8988.00 | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Corvite 150 Oral Tablet - package size 30 | 01/01/2024 | 15.98 | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Corvite FE package size 30 | 01/01/2024 | 21.02 | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Dsuvia - sublingual sufentanil citrate tablet 30 mcg, package size 1 | 73.73 | 73.73 | 58.31 | 01/01/2024 | 6.27 | |
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Dsuvia - sublingual sufentanil citrate tablet 30 mcg, package size 10 | 737.32 | 737.32 | 583.10 | 01/01/2024 | 62.67 | |
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/10mg 30s | 01/30/2024 | 26.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/20mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/20mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/40mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/40mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/80mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/80mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/10mg 30s-New NDC | 01/30/2024 | 26.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/10mg 30s-Old NDC | 01/30/2024 | 26.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/20mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/20mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/40mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/40mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/80mg 30s-New NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/80mg 30s-Old NDC | 01/30/2024 | 35.81 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 1mg 100s | 01/30/2024 | 28.76 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 2mg 100s | 01/30/2024 | 28.76 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 4mg 100s | 01/30/2024 | 30.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 8mg 100s-New NDC | 01/30/2024 | 31.70 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 8mg 100s-Old NDC | 01/30/2024 | 31.70 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 4mg 30s | 01/30/2024 | 9.92 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 8mg 30s-New NDC | 01/30/2024 | 10.42 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 8mg 30s-Old NDC | 01/30/2024 | 10.42 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg 100s | 01/30/2024 | 47.66 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg 500s | 01/30/2024 | 238.32 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg UD100 | 01/30/2024 | 47.66 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 100s-New NDC | 01/30/2024 | 78.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 100s-Old NDC | 01/30/2024 | 78.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 500s | 01/30/2024 | 390.90 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg UD100 | 01/30/2024 | 78.18 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg 60s-New NDC | 01/30/2024 | 70.36 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg 60s-Old NDC | 01/30/2024 | 70.36 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg UD100-New NDC | 01/30/2024 | 117.27 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg UD100-Old NDC | 01/30/2024 | 117.27 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 50mg 60s-New NDC | 01/30/2024 | 13.36 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 50mg 60s-Old NDC | 01/30/2024 | 13.36 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg 1000s | 01/30/2024 | 80.12 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg 100s | 01/30/2024 | 8.01 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg UD100 | 01/30/2024 | 8.84 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 30mg 100s | 01/30/2024 | 6.91 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin Infatabs 50mg 100s | 01/30/2024 | 7.51 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin Infatabs 50mg UD100 | 01/30/2024 | 10.65 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin-125 Oral Suspension 125mg/5mL 237mL | 01/30/2024 | 9.52 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 150mg 30s | 01/30/2024 | 29.82 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 150mg 90s | 01/30/2024 | 89.46 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 37.5mg 30s | 01/30/2024 | 24.43 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 37.5mg 90s | 01/30/2024 | 73.30 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 75mg 30s | 01/30/2024 | 27.38 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 75mg 90s | 01/30/2024 | 82.14 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 20mg 60s | 01/30/2024 | 71.27 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 40mg 60s-New NDC | 01/30/2024 | 71.27 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 40mg 60s-Old NDC | 01/30/2024 | 71.27 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 60mg 60s | 01/30/2024 | 86.49 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 80mg 60s | 01/30/2024 | 86.49 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Injection 20mg/mL SDV 10PK | 01/30/2024 | 30.68 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Inspra Tabs 25mg 30s | 01/30/2024 | 21.12 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Inspra Tabs 50mg 30s | 01/30/2024 | 21.12 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 100mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 100mg UD100 | 01/30/2024 | 53.00 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 150mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 150mg UD100 | 01/30/2024 | 53.00 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 200mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 225mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 25mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 300mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 50mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 50mg UD100 | 01/30/2024 | 53.00 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 75mg 90s | 01/30/2024 | 43.37 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 75mg UD100 | 01/30/2024 | 53.00 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 165mg 30s | 01/30/2024 | 24.84 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 330mg 30s | 01/30/2024 | 24.84 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 82.5mg 30s | 01/30/2024 | 24.84 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 100mg 100s | 01/30/2024 | 13.78 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 300mg 100s | 01/30/2024 | 34.46 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 400mg 100s | 01/30/2024 | 41.34 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Tabs 600mg 100s | 01/30/2024 | 65.46 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Tabs 800mg 100s | 01/30/2024 | 78.54 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.3mg 100s | 01/30/2024 | 3.53 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.4mg 100s | 01/30/2024 | 3.53 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.4mg 100s (Convenience Pack) | 01/30/2024 | 7.70 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.6mg 100s | 01/30/2024 | 3.53 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 10mg 90s | 01/30/2024 | 49.78 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 10mg UD100 | 01/30/2024 | 55.30 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 2.5mg 90s | 01/30/2024 | 36.31 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg 300s | 01/30/2024 | 121.02 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg 90s | 01/30/2024 | 36.31 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg UD100 | 01/30/2024 | 40.34 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 20mg 6s | 01/30/2024 | 23.08 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 40mg 12s | 01/30/2024 | 46.15 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 40mg 6s | 01/30/2024 | 23.08 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Revatio Injection 0.8mg/mL 12.5mL | 01/30/2024 | 12.93 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Revatio Tabs 20mg 90s | 01/30/2024 | 265.09 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xalatan Ophthalmic Drops 0.005% 2.5mL | 01/30/2024 | 12.59 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.25mg 100s | 01/30/2024 | 25.94 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.25mg 500s | 01/30/2024 | 129.71 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.5mg 100s | 01/30/2024 | 32.32 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.5mg 500s | 01/30/2024 | 161.60 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 1mg 100s | 01/30/2024 | 43.13 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 1mg 500s | 01/30/2024 | 215.63 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 2mg 100s | 01/30/2024 | 73.32 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 0.5mg 60s | 01/30/2024 | 30.00 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 1mg 60s | 01/30/2024 | 37.33 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 2mg 60s | 01/30/2024 | 49.54 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 3mg 60s | 01/30/2024 | 74.31 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 100mg 30s | 01/30/2024 | 20.66 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 100mg UD100 | 01/30/2024 | 68.87 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 25mg 30s | 01/30/2024 | 20.66 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 50mg 30s | 01/30/2024 | 20.66 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 50mg UD100 | 01/30/2024 | 68.87 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | DOVATO TAB 50-300MG 30 Tablets per BOTTLE | 01/01/2024 | 166.90 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | JULUCA TAB 50-25MG 30 Tablets per BOTTLE | 01/01/2024 | 196.93 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | RUKOBIA TAB 600MG ER 60 Tablets per BOTTLE | 01/01/2024 | 505.18 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TIVICAY PD TAB 5MG 60 Tablets per BOTTLE | 01/01/2024 | 25.32 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TIVICAY TAB 50MG 30 Tablets per BOTTLE | 01/01/2024 | 126.57 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TRIUMEQ TAB 600-50-300MG 30 Tablets per BOTTLE | 01/01/2024 | 210.12 | ||||
Rx0000223 | Woodward Pharma Services LLC | 03/31/2024 | Lovaza (omega-3-acid ethyl esters) Capsules, 1g, 120 CT | 299.35 | 290.63 | 01/17/2024 | 120.96 | ||
Rx0000380 | Xeris Pharmaceuticals, INC. | 03/31/2024 | Keveyis Oral Tablet 50 MG, | 02/07/2024 | 4864.41 | ||||
Rx0000380 | Xeris Pharmaceuticals, INC. | 03/31/2024 | Keveyis Oral Tablet 50 MG, Dichlorphenamide Tab 50 MG, 100 Each, Bottle | 02/07/2024 | 4864.41 | ||||
Rx0000380 | Xeris Pharmaceuticals, INC. | 10/09/2024 | Recorlev Oral Tablet 150 MG 50 per bottle | 07/01/2024 | 874.85 | ||||
Rx0000163 | Zyla Life Sciences | 07/29/2024 | Sprix (ketorolac tromethamine) 15.75mg/1 Spray, 8 Sprays / Bottle (1 Bottle) | 04/01/2024 | 34.06 | ||||
Rx0000163 | Zyla Life Sciences | 07/29/2024 | Sprix (ketorolac tromethamine) 15.75mg/1 Spray, 8 Sprays per Bottle (5 Bottles per Carton) | 04/01/2024 | 170.31 | ||||
None | None | None | None |